| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | molecular tag activity | 9.22e-06 | 14 | 201 | 4 | GO:0141047 | |
| GeneOntologyMolecularFunction | protein tag activity | 9.22e-06 | 14 | 201 | 4 | GO:0031386 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 8.07e-05 | 9 | 201 | 3 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 8.07e-05 | 9 | 201 | 3 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.14e-04 | 10 | 201 | 3 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.14e-04 | 10 | 201 | 3 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.14e-04 | 10 | 201 | 3 | GO:0046977 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | LIN7C SPTBN2 CLSTN2 RCC2 ENKD1 ALMS1 DMD RAB6A PLS3 RAB27B AGTPBP1 HSP90AB1 FLNA ANK3 HAP1 SYNE1 MYO19 KIF21A CAMSAP3 MYO18A APC DNM1L SIRT2 MACF1 MYBPC3 | 1.18e-04 | 1099 | 201 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 2.07e-04 | 12 | 201 | 3 | GO:0030881 | |
| GeneOntologyMolecularFunction | myosin binding | 2.18e-04 | 85 | 201 | 6 | GO:0017022 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 5.07e-04 | 37 | 201 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | receptor ligand inhibitor activity | 5.97e-04 | 4 | 201 | 2 | GO:0141069 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 6.16e-04 | 17 | 201 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 8.27e-04 | 42 | 201 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.01e-03 | 20 | 201 | 3 | GO:0042608 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 1.25e-03 | 161 | 201 | 7 | GO:0051087 | |
| GeneOntologyBiologicalProcess | intracellular transport | NOLC1 GAK ZC3H11B ADAR PLEKHM1 EHD3 KPNA7 UBB ALMS1 C12orf50 USP7 HERC2 RAB6A AP3D1 RAB27B AGTPBP1 DOP1B HSP90AB1 FLNA MIA3 DNAJC13 ANK3 COPA HAP1 SYNE1 MYO19 CAMSAP3 XPO4 DNM1L TACC2 NUP214 UBE2O RIMS1 VPS13B MYBPC3 | 9.87e-07 | 1496 | 200 | 35 | GO:0046907 |
| GeneOntologyBiologicalProcess | establishment of mitochondrion localization | 3.59e-05 | 39 | 200 | 5 | GO:0051654 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 4.85e-05 | 8 | 200 | 3 | GO:0002485 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | GAK SPTBN2 MFF PLS3 AP3D1 RAB27B HAP1 SYNE1 PCLO DNM1L SIRT2 RIMS1 | 7.41e-05 | 321 | 200 | 12 | GO:0099003 |
| GeneOntologyBiologicalProcess | neuron development | ERBB2 GAK HLA-A HLA-C UNC5B HLA-H UBB ALMS1 ADAM17 ALCAM DMD HERC1 BEX2 RAB6A AGTPBP1 FLNA ANK3 HAP1 SYNE1 CAMSAP3 APC LAMB1 DNM1L DZANK1 FRY THRB FEZ2 MACF1 RIMS1 VPS13B | 7.84e-05 | 1463 | 200 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | RCC2 ENKD1 UBB FCER1A RAB6A AP3D1 AGTPBP1 HAP1 SYNE1 MYO19 PCLO APC DNM1L TACC2 SIRT2 RIMS1 | 8.94e-05 | 546 | 200 | 16 | GO:0051656 |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 9.25e-05 | 25 | 200 | 4 | GO:0002475 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | ERBB2 CDSN HLA-A RCC2 AJAP1 SASH3 MIP DMD AP3D1 RAG1 FLNA MIA3 ANK3 CAMSAP3 APC LAMB1 CYRIB SLC4A2 SLC7A1 MACF1 PEAK1 ZP4 | 1.01e-04 | 927 | 200 | 22 | GO:0030155 |
| GeneOntologyBiologicalProcess | neuron projection development | ERBB2 GAK HLA-A HLA-C UNC5B HLA-H UBB ALMS1 ADAM17 ALCAM DMD HERC1 BEX2 RAB6A FLNA ANK3 HAP1 SYNE1 CAMSAP3 APC LAMB1 DNM1L FRY FEZ2 MACF1 RIMS1 VPS13B | 1.25e-04 | 1285 | 200 | 27 | GO:0031175 |
| GeneOntologyBiologicalProcess | mitochondrial fission | 1.33e-04 | 51 | 200 | 5 | GO:0000266 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | NOLC1 ERBB2 GAK UBL4A ADAR RCC2 MFF KPNA7 BTF3 RAB6A AP3D1 HSP90AB1 FLNA MIA3 POLR1A PMPCB SYNE1 APC DNM1L NUP214 MDC1 MACF1 TNKS TP53BP1 | 1.54e-04 | 1091 | 200 | 24 | GO:0033365 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ERBB2 LIN7C HLA-A HLA-C HLA-H RPS27A RCC2 PLEKHM1 MFF EHD3 UBA52 UBB UBC PIGR ATP13A3 DMD RAB6A AP3D1 RAB27B DOP1B DNAJC13 COPA APC DNM1L SLC12A2 PAM FRMPD3 PCDH7 VPS13B AHNAK2 | 6.64e-06 | 1307 | 199 | 30 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ERBB2 LIN7C HLA-A HLA-C HLA-H RPS27A RCC2 PLEKHM1 MFF EHD3 UBA52 UBB UBC PIGR ATP13A3 DMD RAB6A AP3D1 RAB27B DOP1B DNAJC13 COPA APC DNM1L SLC12A2 PAM FRMPD3 PCDH7 VPS13B AHNAK2 | 8.67e-06 | 1325 | 199 | 30 | GO:0012506 |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.72e-05 | 17 | 199 | 4 | GO:0033106 | |
| GeneOntologyCellularComponent | endosome membrane | ERBB2 HLA-A HLA-C HLA-H RPS27A RCC2 PLEKHM1 EHD3 UBA52 UBB UBC PIGR ATP13A3 AP3D1 RAB27B DOP1B DNAJC13 VPS13B | 1.94e-05 | 602 | 199 | 18 | GO:0010008 |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 2.89e-05 | 7 | 199 | 3 | GO:0032398 | |
| GeneOntologyCellularComponent | costamere | 5.10e-05 | 22 | 199 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 9.71e-05 | 10 | 199 | 3 | GO:0042612 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 9.94e-05 | 112 | 199 | 7 | GO:0055038 | |
| GeneOntologyCellularComponent | anchoring junction | CDSN GAK LIN7C SPTBN2 EHD3 AJAP1 AHNAK MIP ADAM17 ALCAM DMD FLNA ANK3 CAMSAP3 APC SLC4A2 SIRT2 SH3PXD2A MDC1 CGNL1 PEAK1 CDH8 | 1.62e-04 | 976 | 199 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | cytoplasmic region | EFHB NEK4 CFAP54 AP3D1 RAB27B AGTPBP1 HAP1 PCLO CAMSAP3 DNAH2 RIMS1 CFAP46 | 1.83e-04 | 360 | 199 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 2.86e-04 | 14 | 199 | 3 | GO:0042824 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | HLA-A HLA-C HLA-H B4GALNT3 RAB6A AP3D1 RAB27B DOP1B FLNA PCLO MYO18A PAM VPS13B | 3.41e-04 | 443 | 199 | 13 | GO:0098791 |
| GeneOntologyCellularComponent | organelle outer membrane | 3.57e-04 | 279 | 199 | 10 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 3.78e-04 | 281 | 199 | 10 | GO:0019867 | |
| GeneOntologyCellularComponent | transport vesicle | LIN7C HLA-A HLA-C SPTBN2 HLA-H MFF DMD RAB6A RAB27B COPA HAP1 APC DNM1L PAM | 4.72e-04 | 519 | 199 | 14 | GO:0030133 |
| GeneOntologyCellularComponent | mitochondrial outer membrane | 5.23e-04 | 241 | 199 | 9 | GO:0005741 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 5.24e-04 | 293 | 199 | 10 | GO:0030658 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 6.72e-04 | 42 | 199 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | site of polarized growth | 7.40e-04 | 253 | 199 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | EFHB NEK4 CFAP54 AP3D1 RAB27B AGTPBP1 HAP1 CAMSAP3 DNAH2 CFAP46 | 9.57e-04 | 317 | 199 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | early endosome membrane | 9.94e-04 | 212 | 199 | 8 | GO:0031901 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.12e-03 | 48 | 199 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | secretory granule membrane | HLA-C HLA-H PIGR RAB6A RAB27B DNAJC13 PAM FRMPD3 PCDH7 VPS13B | 1.27e-03 | 329 | 199 | 10 | GO:0030667 |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.31e-03 | 23 | 199 | 3 | GO:0005797 | |
| GeneOntologyCellularComponent | Golgi membrane | HLA-A HLA-C SPTBN2 HLA-H CLSTN2 GALNT16 ADAM17 RAB6A AP3D1 DOP1B COPA MYO18A DNM1L CREB3L1 TNKS VPS13B | 1.52e-03 | 721 | 199 | 16 | GO:0000139 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ERBB2 GAK SPTBN2 IRAG1 EHD3 DMD HSP90AB1 HSP90AB3P FLNA HAP1 SYNE1 PCLO APC LAMB1 DNM1L SIRT2 PAM LTBP1 CDC25C | 1.55e-03 | 934 | 199 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | cell-cell junction | CDSN LIN7C SPTBN2 AJAP1 AHNAK MIP ADAM17 FLNA ANK3 CAMSAP3 APC SIRT2 CGNL1 CDH8 | 1.64e-03 | 591 | 199 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | lateral loop | 1.83e-03 | 7 | 199 | 2 | GO:0043219 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.88e-03 | 26 | 199 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | presynapse | ERBB2 GAK LIN7C SPTBN2 RPS27A MFF UBA52 DMD RAB6A AP3D1 RAB27B HAP1 PCLO APC DNM1L SLC6A3 RIMS1 CDH8 | 2.08e-03 | 886 | 199 | 18 | GO:0098793 |
| GeneOntologyCellularComponent | axon | ALCAM DMD AP3D1 RAB27B AGTPBP1 HSP90AB1 FLNA TSHZ3 ANK3 COPA HAP1 KIF21A PCLO APC SLC6A3 SIRT2 FEZ2 CDH8 | 2.21e-03 | 891 | 199 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | early endosome | ERBB2 HLA-A HLA-C HLA-H RCC2 EHD3 ATP13A3 AP3D1 DOP1B DNAJC13 HAP1 VPS13B | 2.29e-03 | 481 | 199 | 12 | GO:0005769 |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 2.43e-03 | 8 | 199 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | growth cone | 2.47e-03 | 245 | 199 | 8 | GO:0030426 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 3.11e-03 | 9 | 199 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | distal axon | AP3D1 HSP90AB1 FLNA TSHZ3 COPA HAP1 PCLO APC SLC6A3 SIRT2 CDH8 | 3.12e-03 | 435 | 199 | 11 | GO:0150034 |
| Domain | Ubiquitin_CS | 3.07e-08 | 10 | 198 | 5 | IPR019954 | |
| Domain | Ubiquitin | 5.59e-08 | 11 | 198 | 5 | IPR019956 | |
| Domain | ACTININ_2 | 1.14e-07 | 23 | 198 | 6 | PS00020 | |
| Domain | ACTININ_1 | 1.14e-07 | 23 | 198 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.14e-07 | 23 | 198 | 6 | IPR001589 | |
| Domain | UBIQUITIN_1 | 2.33e-06 | 37 | 198 | 6 | PS00299 | |
| Domain | UBQ | 5.79e-06 | 43 | 198 | 6 | SM00213 | |
| Domain | CH | 9.22e-06 | 70 | 198 | 7 | PF00307 | |
| Domain | ubiquitin | 9.84e-06 | 47 | 198 | 6 | PF00240 | |
| Domain | CH | 1.22e-05 | 73 | 198 | 7 | PS50021 | |
| Domain | CH-domain | 1.46e-05 | 75 | 198 | 7 | IPR001715 | |
| Domain | UBIQUITIN_2 | 2.23e-05 | 54 | 198 | 6 | PS50053 | |
| Domain | MHC_I_a_C | 2.29e-05 | 6 | 198 | 3 | IPR010579 | |
| Domain | MHC_I_C | 2.29e-05 | 6 | 198 | 3 | PF06623 | |
| Domain | Ubiquitin_dom | 3.37e-05 | 58 | 198 | 6 | IPR000626 | |
| Domain | CH | 6.46e-05 | 65 | 198 | 6 | SM00033 | |
| Domain | Spectrin | 9.26e-05 | 23 | 198 | 4 | PF00435 | |
| Domain | - | 1.06e-04 | 71 | 198 | 6 | 1.10.418.10 | |
| Domain | PDZ | 2.11e-04 | 151 | 198 | 8 | PS50106 | |
| Domain | PDZ | 2.21e-04 | 152 | 198 | 8 | IPR001478 | |
| Domain | Spectrin_repeat | 2.36e-04 | 29 | 198 | 4 | IPR002017 | |
| Domain | SNF2_N | 3.49e-04 | 32 | 198 | 4 | IPR000330 | |
| Domain | SNF2_N | 3.49e-04 | 32 | 198 | 4 | PF00176 | |
| Domain | SPEC | 3.49e-04 | 32 | 198 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.49e-04 | 32 | 198 | 4 | IPR018159 | |
| Domain | PDZ | 7.73e-04 | 141 | 198 | 7 | PF00595 | |
| Domain | Ubiquitin-rel_dom | 7.90e-04 | 184 | 198 | 8 | IPR029071 | |
| Domain | PDZ | 1.03e-03 | 148 | 198 | 7 | SM00228 | |
| Domain | Protocadherin | 1.09e-03 | 5 | 198 | 2 | PF08374 | |
| Domain | Protocadherin | 1.09e-03 | 5 | 198 | 2 | IPR013585 | |
| Domain | - | 1.11e-03 | 150 | 198 | 7 | 2.30.42.10 | |
| Domain | RCC1 | 1.17e-03 | 20 | 198 | 3 | PF00415 | |
| Domain | CADHERIN_1 | 1.30e-03 | 113 | 198 | 6 | PS00232 | |
| Domain | Cadherin | 1.30e-03 | 113 | 198 | 6 | PF00028 | |
| Domain | MHC_I | 1.36e-03 | 21 | 198 | 3 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.36e-03 | 21 | 198 | 3 | IPR001039 | |
| Domain | RCC1_1 | 1.36e-03 | 21 | 198 | 3 | PS00625 | |
| Domain | RCC1_2 | 1.36e-03 | 21 | 198 | 3 | PS00626 | |
| Domain | RCC1_3 | 1.36e-03 | 21 | 198 | 3 | PS50012 | |
| Domain | CADHERIN_2 | 1.36e-03 | 114 | 198 | 6 | PS50268 | |
| Domain | - | 1.36e-03 | 114 | 198 | 6 | 2.60.40.60 | |
| Domain | CA | 1.42e-03 | 115 | 198 | 6 | SM00112 | |
| Domain | Cadherin-like | 1.49e-03 | 116 | 198 | 6 | IPR015919 | |
| Domain | - | 1.56e-03 | 22 | 198 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 1.56e-03 | 22 | 198 | 3 | IPR000408 | |
| Domain | Cadherin | 1.62e-03 | 118 | 198 | 6 | IPR002126 | |
| Domain | RCC1/BLIP-II | 1.78e-03 | 23 | 198 | 3 | IPR009091 | |
| Pathway | REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC | 9.05e-09 | 4 | 139 | 4 | MM15591 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_LOCALIZATION | 1.06e-08 | 9 | 139 | 5 | M27814 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_LOCALIZATION | 2.10e-08 | 10 | 139 | 5 | MM15539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_UCHL1_MEDIATED_HYDROLYSIS | 4.49e-08 | 5 | 139 | 4 | M49036 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 6.50e-08 | 12 | 139 | 5 | MM14550 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 1.05e-07 | 13 | 139 | 5 | M549 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 2.41e-07 | 15 | 139 | 5 | M27202 | |
| Pathway | REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS | 3.10e-07 | 7 | 139 | 4 | M41737 | |
| Pathway | REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS | 3.10e-07 | 7 | 139 | 4 | MM15593 | |
| Pathway | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | 3.10e-07 | 7 | 139 | 4 | MM15592 | |
| Pathway | REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM | 3.10e-07 | 7 | 139 | 4 | M29822 | |
| Pathway | REACTOME_TRANSLESION_SYNTHESIS_BY_POLH | 9.02e-07 | 19 | 139 | 5 | MM14477 | |
| Pathway | REACTOME_TRANSLESION_SYNTHESIS_BY_POLH | 9.02e-07 | 19 | 139 | 5 | M26899 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 9.57e-07 | 78 | 139 | 8 | M973 | |
| Pathway | REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1 | 1.10e-06 | 9 | 139 | 4 | M27732 | |
| Pathway | REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS | 1.10e-06 | 9 | 139 | 4 | M27781 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING | 1.10e-06 | 9 | 139 | 4 | M26930 | |
| Pathway | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | 1.10e-06 | 9 | 139 | 4 | MM14676 | |
| Pathway | REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION | 1.10e-06 | 9 | 139 | 4 | M29819 | |
| Pathway | REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA | 1.10e-06 | 9 | 139 | 4 | M27276 | |
| Pathway | REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1 | 1.10e-06 | 9 | 139 | 4 | MM15482 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING | 1.10e-06 | 9 | 139 | 4 | MM14535 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 1.36e-06 | 57 | 139 | 7 | MM15298 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.82e-06 | 10 | 139 | 4 | MM14849 | |
| Pathway | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX | 1.82e-06 | 10 | 139 | 4 | MM15647 | |
| Pathway | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX | 1.82e-06 | 10 | 139 | 4 | M27925 | |
| Pathway | REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY | 2.00e-06 | 22 | 139 | 5 | M27937 | |
| Pathway | REACTOME_REGULATION_OF_BACH1_ACTIVITY | 2.83e-06 | 11 | 139 | 4 | M41833 | |
| Pathway | REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX | 2.83e-06 | 11 | 139 | 4 | M27885 | |
| Pathway | REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY | 2.83e-06 | 11 | 139 | 4 | MM15668 | |
| Pathway | REACTOME_PEXOPHAGY | 2.83e-06 | 11 | 139 | 4 | MM15673 | |
| Pathway | REACTOME_REGULATION_OF_BACH1_ACTIVITY | 2.83e-06 | 11 | 139 | 4 | MM15686 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION | 2.83e-06 | 11 | 139 | 4 | M48241 | |
| Pathway | REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY | 2.83e-06 | 11 | 139 | 4 | M29827 | |
| Pathway | REACTOME_PEXOPHAGY | 2.83e-06 | 11 | 139 | 4 | M29846 | |
| Pathway | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B | 3.17e-06 | 24 | 139 | 5 | MM14675 | |
| Pathway | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B | 3.17e-06 | 24 | 139 | 5 | M1039 | |
| Pathway | REACTOME_JOSEPHIN_DOMAIN_DUBS | 4.21e-06 | 12 | 139 | 4 | M27577 | |
| Pathway | REACTOME_JOSEPHIN_DOMAIN_DUBS | 4.21e-06 | 12 | 139 | 4 | MM15288 | |
| Pathway | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | 4.83e-06 | 26 | 139 | 5 | MM14697 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 4.83e-06 | 26 | 139 | 5 | MM15501 | |
| Pathway | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | 4.83e-06 | 26 | 139 | 5 | M1079 | |
| Pathway | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | 6.04e-06 | 13 | 139 | 4 | MM14827 | |
| Pathway | REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | 6.04e-06 | 13 | 139 | 4 | MM14828 | |
| Pathway | REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION | 6.04e-06 | 13 | 139 | 4 | MM15280 | |
| Pathway | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | 6.04e-06 | 13 | 139 | 4 | M14582 | |
| Pathway | REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7 | 6.04e-06 | 13 | 139 | 4 | M27884 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | 6.04e-06 | 13 | 139 | 4 | M967 | |
| Pathway | REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION | 6.04e-06 | 13 | 139 | 4 | M29823 | |
| Pathway | REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA | 6.04e-06 | 13 | 139 | 4 | MM14931 | |
| Pathway | REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | 6.04e-06 | 13 | 139 | 4 | M736 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 7.10e-06 | 28 | 139 | 5 | M41724 | |
| Pathway | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | 8.39e-06 | 14 | 139 | 4 | MM14826 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FLT3 | 8.39e-06 | 14 | 139 | 4 | MM15682 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 8.39e-06 | 14 | 139 | 4 | M935 | |
| Pathway | REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING | 8.39e-06 | 14 | 139 | 4 | MM15642 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7 | 8.39e-06 | 14 | 139 | 4 | M48239 | |
| Pathway | REACTOME_GLYCOGEN_SYNTHESIS | 8.39e-06 | 14 | 139 | 4 | M27247 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR | 8.39e-06 | 14 | 139 | 4 | M47975 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 8.51e-06 | 29 | 139 | 5 | M27756 | |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 8.84e-06 | 75 | 139 | 7 | MM15299 | |
| Pathway | REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES | 1.01e-05 | 30 | 139 | 5 | M27762 | |
| Pathway | REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES | 1.01e-05 | 30 | 139 | 5 | MM15507 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | 1.14e-05 | 15 | 139 | 4 | MM14875 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FLT3 | 1.14e-05 | 15 | 139 | 4 | M41735 | |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | 1.14e-05 | 15 | 139 | 4 | MM15175 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 1.14e-05 | 15 | 139 | 4 | MM15645 | |
| Pathway | REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL | 1.14e-05 | 15 | 139 | 4 | M27774 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7 | 1.14e-05 | 15 | 139 | 4 | MM17228 | |
| Pathway | REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA | 1.14e-05 | 15 | 139 | 4 | M27229 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 1.15e-05 | 78 | 139 | 7 | M27589 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.20e-05 | 31 | 139 | 5 | M592 | |
| Pathway | REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES | 1.41e-05 | 32 | 139 | 5 | MM15290 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.41e-05 | 32 | 139 | 5 | MM14975 | |
| Pathway | REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION | 1.50e-05 | 16 | 139 | 4 | M27567 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 1.50e-05 | 16 | 139 | 4 | MM14873 | |
| Pathway | REACTOME_ASSEMBLY_OF_THE_HIV_VIRION | 1.50e-05 | 16 | 139 | 4 | M27033 | |
| Pathway | REACTOME_P75NTR_SIGNALS_VIA_NF_KB | 1.50e-05 | 16 | 139 | 4 | M18175 | |
| Pathway | REACTOME_P75NTR_SIGNALS_VIA_NF_KB | 1.50e-05 | 16 | 139 | 4 | MM14742 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 1.50e-05 | 16 | 139 | 4 | M514 | |
| Pathway | REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION | 1.50e-05 | 16 | 139 | 4 | M27761 | |
| Pathway | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | 1.50e-05 | 16 | 139 | 4 | M7257 | |
| Pathway | REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION | 1.50e-05 | 16 | 139 | 4 | MM15506 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | 1.50e-05 | 16 | 139 | 4 | M627 | |
| Pathway | REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX | 1.50e-05 | 16 | 139 | 4 | M1000 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 1.50e-05 | 16 | 139 | 4 | MM14903 | |
| Pathway | REACTOME_GLYCOGEN_STORAGE_DISEASES | 1.50e-05 | 16 | 139 | 4 | M27236 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 1.50e-05 | 16 | 139 | 4 | MM14541 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 1.65e-05 | 33 | 139 | 5 | MM14666 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 1.92e-05 | 34 | 139 | 5 | MM15566 | |
| Pathway | REACTOME_TRANSLESION_SYNTHESIS_BY_POLK | 1.95e-05 | 17 | 139 | 4 | M27537 | |
| Pathway | REACTOME_TRANSLESION_SYNTHESIS_BY_POLK | 1.95e-05 | 17 | 139 | 4 | MM15259 | |
| Pathway | REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING | 1.95e-05 | 17 | 139 | 4 | MM15702 | |
| Pathway | REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX | 1.95e-05 | 17 | 139 | 4 | MM15648 | |
| Pathway | REACTOME_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE | 2.22e-05 | 35 | 139 | 5 | MM14689 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION | 2.49e-05 | 18 | 139 | 4 | MM15342 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 2.49e-05 | 18 | 139 | 4 | MM15680 | |
| Pathway | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_IKBKE | 2.49e-05 | 18 | 139 | 4 | M970 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.49e-05 | 18 | 139 | 4 | MM14775 | |
| Pathway | REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING | 2.49e-05 | 18 | 139 | 4 | M45023 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 SDE2 GAK PFAS CHD1 LRRC59 RPS27A ADAR RCC2 PTPN13 GSE1 ALMS1 BTF3 AHNAK USP7 AP3D1 PRRC2B HSP90AB1 TTF2 FLNA L3MBTL2 TCOF1 DNM1L TACC2 BTAF1 NUP214 UBE2O SIRT2 MACF1 CGNL1 TP53BP1 AHNAK2 HDLBP | 1.30e-16 | 934 | 204 | 33 | 33916271 |
| Pubmed | NOLC1 GAK HLA-A HLA-C UNC5B SPTBN2 UBL4A SRPK1 PFAS CHD1 LRRC59 RPS27A GTF3C3 PTPN13 HERC2 SLC30A9 PLS3 AP3D1 AGTPBP1 DPH2 MIA3 DNAJC13 ANK3 L3MBTL2 TCOF1 HSDL2 PMPCB SYNE1 MYO18A LAMB1 SLC4A2 UBE2O SLC12A2 MACF1 PEAK1 PCDH7 VPS13B TP53BP1 HDLBP | 3.21e-15 | 1487 | 204 | 39 | 33957083 | |
| Pubmed | NOLC1 SLCO2B1 SPTBN2 LRRC59 RPS27A RAD54L2 UBA52 UBB UBC EFCAB12 AHNAK ALCAM DMD AP3D1 PRRC2B HSP90AB1 HSPE1 FLNA PCDHGC5 COPA PMPCB SYNE1 PCDHGA1 KIF21A PCLO CAMSAP3 DNAH2 MYO18A RNF17 NARS2 SETD5 SH3PXD2A PAEP MACF1 RIMS1 CFAP46 | 1.87e-13 | 1442 | 204 | 36 | 35575683 | |
| Pubmed | SRPK1 ADAR RCC2 UBB AHNAK USP7 DMD HERC1 HSP90AB1 FLNA SYNE1 NSD1 MDC1 MACF1 CGNL1 VPS13B | 8.09e-13 | 234 | 204 | 16 | 36243803 | |
| Pubmed | NOLC1 SPTBN2 SRPK1 PFAS CHD1 RCC2 GTF3C3 AHNAK USP7 HERC2 PRRC2B FLNA POLR1A COPA TCOF1 NSD1 NUP214 UBE2O PHF3 MDC1 MACF1 ZMYM3 TP53BP1 HDLBP | 1.10e-12 | 653 | 204 | 24 | 22586326 | |
| Pubmed | GAK SPTBN2 ADAR GTF3C3 UBA52 PTPN13 ALMS1 AHNAK USP7 PLS3 PRRC2B TTF2 FLNA ANK3 TCOF1 NSD1 UBE2O PHF3 MDC1 PEAK1 TP53BP1 HDLBP | 1.89e-12 | 549 | 204 | 22 | 38280479 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | SDE2 HLA-A HLA-C UBL4A LRRC59 GTF3C3 UBC ALG5 SLC30A9 RAB6A HSP90AB1 TTF2 FLNA MIA3 UBQLN2 POLR1A COPA TCOF1 HSDL2 DNAH2 BTAF1 NUP214 SLC4A2 SLC7A1 UBE2O SLC12A2 ZMYM3 HDLBP | 2.10e-12 | 942 | 204 | 28 | 31073040 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 GSE1 USP7 AGTPBP1 HSP90AB1 FLNA DNAJC13 SFSWAP COPA TCOF1 CAMSAP3 MYO18A BTAF1 NUP214 KANSL1 PHF3 CHTF18 MDC1 EIF3B RIMS1 CDK11B PCDH7 ZMYM3 TP53BP1 HDLBP | 5.98e-12 | 774 | 204 | 25 | 15302935 |
| Pubmed | PRPF31 GAK LIN7C HLA-A HLA-C SRPK1 LRRC59 RPS27A ADAR MFF BTF3 AHNAK RAB6A PLS3 AP3D1 PRRC2B HSP90AB1 HSPE1 FLNA MIA3 DNAJC13 UBQLN2 COPA TCOF1 KIF21A APC LAMB1 DNM1L NUP214 MDC1 MACF1 TP53BP1 | 6.63e-12 | 1297 | 204 | 32 | 33545068 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 PRPF31 CDSN SPTBN2 LRRC59 RPS27A ZSCAN25 ADAR RCC2 GTF3C3 PTPN13 USP7 PZP AP3D1 HSP90AB1 HSPE1 DNAJC13 SFSWAP COPA TCOF1 SYNE1 MYO18A APC HS1BP3 MACF1 EIF3B CDK11B PAN3 ZMYM3 | 1.01e-11 | 1082 | 204 | 29 | 38697112 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 PRPF31 CDSN SRPK1 PFAS CHD1 ADAR GTF3C3 AHNAK USP7 HERC2 AP3D1 HSP90AB1 TTF2 FLNA DNAJC13 POLR1A COPA L3MBTL2 PMPCB MYO19 KIF21A NUP214 KANSL1 CHTF18 MDC1 MACF1 EIF3B ZMYM3 TP53BP1 AHNAK2 HDLBP | 1.97e-11 | 1353 | 204 | 32 | 29467282 |
| Pubmed | HLA-A HLA-C SPTBN2 PFAS PTPN13 GSE1 AHNAK USP7 HERC2 DMD HERC1 AGTPBP1 PRRC2B HSP90AB1 MIA3 DNAJC13 ANK3 COPA HSDL2 PMPCB CAMSAP3 XPO4 SLC12A2 LTBP1 PEAK1 CDC25C PCDH7 HDLBP | 2.61e-11 | 1049 | 204 | 28 | 27880917 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | GAK PFAS RAD54L2 UBB UBC GSE1 ALMS1 USP7 RAB6A PRRC2B TCOF1 APC TACC2 SIRT2 MACF1 CDK11B CGNL1 SPRTN ZMYM3 TP53BP1 HDLBP | 5.24e-11 | 588 | 204 | 21 | 38580884 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 PRPF31 CDSN HLA-A HLA-C PFAS CHD1 LRRC59 ADAR RCC2 GTF3C3 UBB USP7 PLS3 HSP90AB1 HSPE1 FLNA POLR1A COPA TCOF1 HSDL2 PMPCB SYNE1 PCLO DNM1L NUP214 UBE2O MDC1 EIF3B PEAK1 HDLBP | 3.29e-10 | 1425 | 204 | 31 | 30948266 |
| Pubmed | GAK SPTBN2 LRRC59 EHD3 C12orf50 USP7 DMD PLS3 AP3D1 AGTPBP1 PRRC2B HSP90AB1 FLNA DNAJC13 ANK3 COPA SYNE1 PCLO CAMSAP3 MYO18A APC DNM1L CYRIB DZANK1 UBE2O SIRT2 MACF1 RIMS1 CGNL1 PEAK1 HDLBP | 3.64e-10 | 1431 | 204 | 31 | 37142655 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | PRPF31 LRRC59 RPS27A CPED1 ADAR PTPN13 BTF3 AHNAK AGTPBP1 PRRC2B FLNA CNOT11 DNAJC13 POLR1A COPA MYO18A APC SH3PXD2A PHF3 MACF1 AHNAK2 HDLBP | 3.80e-10 | 724 | 204 | 22 | 36232890 |
| Pubmed | SRPK1 LRRC59 RPS27A RCC2 GTF3C3 AHNAK USP7 DMD PLS3 AP3D1 HSP90AB1 HSPE1 TTF2 FLNA CNOT11 COPA TCOF1 HSDL2 APC DNM1L DZANK1 EIF3B HDLBP | 5.35e-10 | 809 | 204 | 23 | 32129710 | |
| Pubmed | SPTBN2 RPS27A EHD3 HERC2 PRRC2B HSP90AB1 MIA3 DNAJC13 ANK3 TCOF1 SYNE1 KIF21A CAMSAP3 NSD1 APC DNM1L CYRIB DZANK1 FRY UBE2O MACF1 TNKS RIMS1 FRMPD3 TP53BP1 | 5.87e-10 | 963 | 204 | 25 | 28671696 | |
| Pubmed | SPTBN2 ENKD1 UBA52 UBC HERC2 DMD HSP90AB1 FLNA ANK3 SYNE1 MYO18A APC LAMB1 NUP214 KANSL1 MACF1 CGNL1 HDLBP | 7.50e-10 | 486 | 204 | 18 | 20936779 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PRPF31 LIN7C SPTBN2 PFAS LRRC59 RPS27A ADAR RCC2 GTF3C3 BTF3 AHNAK USP7 PLS3 AP3D1 HSP90AB1 HSPE1 FLNA ANK3 COPA TCOF1 CAMSAP3 MYO18A DNM1L UBE2O MACF1 EIF3B HDLBP | 9.95e-10 | 1149 | 204 | 27 | 35446349 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 PRPF31 SRPK1 PFAS CHD1 LRRC59 RPS27A RCC2 ARL6IP4 BTF3 AHNAK USP7 PLS3 AP3D1 HSP90AB1 HSPE1 FLNA CNOT11 COPA TCOF1 HSDL2 KIF21A TACC2 UBE2O CHTF18 MDC1 MACF1 EIF3B AHNAK2 HDLBP | 1.20e-09 | 1415 | 204 | 30 | 28515276 |
| Pubmed | ZC3H11B ADAR AHNAK PRRC2B HSP90AB1 FLNA COPA L3MBTL2 TENT5A NSD1 SETD5 MACF1 EIF3B SPRTN AHNAK2 | 1.43e-09 | 332 | 204 | 15 | 37433992 | |
| Pubmed | ERBB2 HLA-A UNC5B LRRC59 RCC2 PTPN13 AHNAK PLS3 AP3D1 HSP90AB1 TTF2 ANK3 COPA TCOF1 APC DNM1L NUP214 MACF1 PEAK1 PCDH7 HDLBP | 1.50e-09 | 708 | 204 | 21 | 39231216 | |
| Pubmed | BCAT1 RPS27A UBA52 UBB UBC PTPN13 AHNAK PZP HSP90AB1 HSPE1 LAMB1 NUP214 CHTF18 LTBP1 | 1.68e-09 | 284 | 204 | 14 | 29459677 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 PRPF31 ERBB2 ENKD1 NEK4 PTPN13 ALMS1 AHNAK DOP1B CAMSAP3 APC DNM1L NARS2 SLC12A2 SH3PXD2A PHF3 MACF1 CGNL1 PEAK1 PAN3 CDC25C PCDH7 AHNAK2 | 1.75e-09 | 861 | 204 | 23 | 36931259 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 PRPF31 HLA-A HLA-C SPTBN2 CHD1 LRRC59 ADAR RCC2 UBC AHNAK HERC2 HSP90AB1 FLNA POLR1A COPA TCOF1 SYNE1 BTAF1 NUP214 SLC12A2 MDC1 MACF1 EIF3B HDLBP | 2.04e-09 | 1024 | 204 | 25 | 24711643 |
| Pubmed | HLA-C UNC5B LRRC59 RPS27A UBA52 UBB UBC PTPN13 AHNAK ALG5 ADAM17 SLC30A9 RAB6A HSP90AB1 MIA3 COPA HSDL2 PMPCB SLC4A2 TMX2 SLC7A1 UBE2O SLC12A2 PCDH7 | 2.36e-09 | 952 | 204 | 24 | 38569033 | |
| Pubmed | NOLC1 CHD1 RPS27A UBB BTF3 AHNAK DMD HSP90AB1 HSP90AB3P FLNA LAMB1 UBE2O CHTF18 MACF1 EIF3B CDK11B FRMPD3 AHNAK2 | 3.70e-09 | 538 | 204 | 18 | 28524877 | |
| Pubmed | NOLC1 LIN7C HLA-A SRPK1 PFAS LRRC59 RPS27A RCC2 ARL6IP4 UBA52 UBB BTF3 USP7 HSP90AB1 ANKRD35 HSPE1 FLNA COPA TCOF1 KIF21A APC LAMB1 NUP214 PHF3 CHTF18 EIF3B HDLBP | 5.67e-09 | 1247 | 204 | 27 | 27684187 | |
| Pubmed | PTPN13 ALMS1 AP3D1 PRRC2B MIA3 ANK3 APC UBE2O SLC12A2 MACF1 PEAK1 VPS13B AHNAK2 | 6.29e-09 | 263 | 204 | 13 | 34702444 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | RAD54L2 AHNAK USP7 HSP90AB1 FLNA COPA DNM1L NUP214 PHF3 MDC1 ZMYM3 TP53BP1 AHNAK2 HDLBP | 1.22e-08 | 332 | 204 | 14 | 32786267 |
| Pubmed | 1.27e-08 | 14 | 204 | 5 | 17242355 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | LRRC59 CLSTN2 UBC AHNAK USP7 RAB6A AP3D1 HSP90AB1 FLNA MIA3 ANK3 COPA SYNE1 PCLO CYRIB SLC12A2 MACF1 EIF3B PEAK1 AHNAK2 HDLBP | 1.47e-08 | 807 | 204 | 21 | 30575818 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | NOLC1 ERBB2 LRRC59 RPS27A MFF UBB ALMS1 MINDY4 HERC2 HERC1 SLC30A9 PRRC2B HSPE1 TTF2 MIA3 UBQLN2 COPA HSDL2 PMPCB SYNE1 MYO19 PCLO DNM1L TACC2 NARS2 SIRT2 SLC12A2 VPS13B AHNAK2 | 1.69e-08 | 1496 | 204 | 29 | 32877691 |
| Pubmed | 1.71e-08 | 6 | 204 | 4 | 8702753 | ||
| Pubmed | ERBB2 HLA-C SRPK1 CHD1 ADAR GTF3C3 MFF UBC AHNAK AP3D1 FLNA DNAJC13 POLR1A COPA MYO18A DNM1L MACF1 HDLBP | 2.03e-08 | 601 | 204 | 18 | 33658012 | |
| Pubmed | PFAS RPS27A ALG5 USP7 DMD RAB6A FLNA COPA TCOF1 HSDL2 SYNE1 TENT5A DNAH2 MYO18A LAMB1 NUP214 RNF17 RASL11A MDC1 HDLBP | 2.41e-08 | 754 | 204 | 20 | 35906200 | |
| Pubmed | NOLC1 LRRC59 RAD54L2 RCC2 GTF3C3 GSE1 ALMS1 USP7 HERC2 HERC1 PRRC2B HSPE1 TSHZ3 CNOT11 COPA L3MBTL2 MYO18A NUP214 ZFPM2 UBE2O KANSL1 MDC1 EIF3B PAN3 PCDH7 ZMYM3 TP53BP1 MYB | 2.44e-08 | 1429 | 204 | 28 | 35140242 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RCC2 BTF3 HERC2 PZP AP3D1 PRRC2B COPA HSDL2 CAMSAP3 APC NUP214 FRY KANSL1 TNKS TP53BP1 HDLBP | 2.56e-08 | 475 | 204 | 16 | 31040226 |
| Pubmed | NOLC1 EHD3 UBC PTPN13 ADAM17 HERC1 ANKRD40 FLNA MIA3 ANK3 HSDL2 ANAPC15 NSD1 APC DNM1L TACC2 SLC7A1 FEZ2 SETD5 MACF1 PEAK1 PAN3 VPS13B TP53BP1 | 2.82e-08 | 1084 | 204 | 24 | 11544199 | |
| Pubmed | NOLC1 GAK HLA-A SPTBN2 UBL4A SRPK1 LRRC59 RPS27A RCC2 BTF3 AHNAK ALG5 USP7 ATP13A3 SLC30A9 PLS3 AP3D1 PRRC2B FLNA COPA MYO19 LAMB1 XPO4 BTAF1 CYRIB MDC1 EIF3B AHNAK2 | 2.87e-08 | 1440 | 204 | 28 | 30833792 | |
| Pubmed | HLA-A SPTBN2 RPS27A RAD54L2 UBC PTPN13 USP7 HERC2 RAB6A AGTPBP1 DOP1B HSP90AB1 UBQLN2 ANK3 COPA TCOF1 SYNE1 KIF21A APC ZNF343 LAMB1 FRY UBE2O ZNF197 MACF1 TNKS | 4.32e-08 | 1285 | 204 | 26 | 35914814 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | HLA-A HLA-C CHD1 LRRC59 GTF3C3 GSE1 AHNAK ALG5 ADAM17 ALCAM SLC30A9 AP3D1 HSP90AB1 FLNA MIA3 DNAJC13 TCOF1 CYRIB TMX2 SLC7A1 SLC12A2 PHF3 TNKS ZMYM3 TP53BP1 | 4.83e-08 | 1203 | 204 | 25 | 29180619 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 HLA-C SPTBN2 LRRC59 RPS27A ADAR RCC2 UBA52 BTF3 AHNAK USP7 AP3D1 HSP90AB1 FLNA POLR1A COPA TCOF1 SYNE1 MYO18A MDC1 EIF3B CDK11B | 5.03e-08 | 949 | 204 | 22 | 36574265 |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | NOLC1 RPS27A UBA52 UBB UBC DMD AP3D1 HSP90AB1 FLNA POLR1A TCOF1 LRP11 HDLBP | 5.70e-08 | 317 | 204 | 13 | 17620599 |
| Pubmed | LRRC59 MFF PTPN13 FDXR DMD FLNA MIA3 UBQLN2 COPA SLC6A3 TMX2 MACF1 PEAK1 | 6.83e-08 | 322 | 204 | 13 | 26514267 | |
| Pubmed | PRPF31 LIN7C PFAS RPS27A BTF3 AHNAK USP7 ANKRD40 FLNA MIA3 LAMB1 HDLBP | 6.93e-08 | 267 | 204 | 12 | 33417871 | |
| Pubmed | NOLC1 LRRC59 RPS27A BTF3 TMCC2 USP7 HSP90AB1 HSPE1 FLNA MIA3 ANK3 PCLO CAMSAP3 MYO18A APC TACC2 DZANK1 UBE2O MACF1 EIF3B RIMS1 PEAK1 TP53BP1 HDLBP | 7.09e-08 | 1139 | 204 | 24 | 36417873 | |
| Pubmed | 7.90e-08 | 8 | 204 | 4 | 15728484 | ||
| Pubmed | An MHC class Ib-restricted TCR that cross-reacts with an MHC class Ia molecule. | 7.90e-08 | 8 | 204 | 4 | 15944277 | |
| Pubmed | 7.90e-08 | 8 | 204 | 4 | 27717799 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | RPS27A ADAR UBA52 UBB UBC AHNAK RAB6A FLNA TCOF1 MDC1 TP53BP1 HDLBP | 8.15e-08 | 271 | 204 | 12 | 32433965 |
| Pubmed | BCAT1 RPS27A UBA52 UBB UBC PLAGL1 HERC2 HERC1 TTF2 FLNA UBQLN2 ANK3 TENT5A KANSL1 MACF1 SPRTN HDLBP | 9.06e-08 | 591 | 204 | 17 | 15231748 | |
| Pubmed | GAK HLA-A HLA-C LRRC59 RPS27A ADAR AHNAK ALG5 ADAM17 ATP13A3 HERC2 AP3D1 HSP90AB1 FLNA MIA3 DNAJC13 COPA HSDL2 MYO18A DNM1L SLC4A2 SLC7A1 CHTF18 PAM | 1.13e-07 | 1168 | 204 | 24 | 19946888 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | SPTBN2 AHNAK ANK3 SYNE1 PCLO CAMSAP3 DNM1L DZANK1 PHF3 MACF1 RIMS1 PCDH7 | 1.21e-07 | 281 | 204 | 12 | 28706196 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | GAK HLA-A HLA-C HLA-H LRRC59 RPS27A ADAR BTF3 AHNAK FDXR ALG5 ADAM17 RAB6A AP3D1 HSP90AB1 ANKRD35 HSPE1 FLNA COPA LAMB1 NARS2 SLC4A2 TMX2 PAM LTBP1 CDK11B HDLBP | 1.26e-07 | 1451 | 204 | 27 | 30550785 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PRPF31 SDE2 CHD1 LRRC59 GTF3C3 USP7 HERC2 TSHZ3 L3MBTL2 BAZ2B NSD1 BTAF1 UBE2O PHF3 MDC1 CDK11B ZMYM3 | 1.35e-07 | 608 | 204 | 17 | 36089195 |
| Pubmed | 1.42e-07 | 9 | 204 | 4 | 21135169 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NOLC1 CDSN LIN7C PFAS LRRC59 ADAR RCC2 BTF3 AHNAK ALCAM PRRC2B HSP90AB1 HSPE1 FLNA DNAJC13 COPA TCOF1 KIF21A MYO18A NUP214 CYRIB UBE2O CHTF18 TP53BP1 AHNAK2 HDLBP | 1.45e-07 | 1367 | 204 | 26 | 32687490 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SPTBN2 SRPK1 RPS27A ADAR UBB BTF3 PLS3 AP3D1 HSP90AB1 HSP90AB3P TTF2 FLNA MIA3 POLR1A COPA KIF21A DNAH2 DNM1L MACF1 EIF3B | 1.58e-07 | 847 | 204 | 20 | 35235311 |
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | HLA-A SRPK1 LRRC59 RPS27A GTF3C3 GSE1 BTF3 ALG5 ANKRD40 AP3D1 HSP90AB1 TCOF1 MDC1 EIF3B HDLBP | 1.86e-07 | 480 | 204 | 15 | 25437307 |
| Pubmed | NOLC1 RPS27A GTF3C3 MFF PTPN13 AHNAK AP3D1 PRRC2B HSPE1 DNAJC13 ANK3 SFSWAP TCOF1 APC DNM1L SLC12A2 CGNL1 PEAK1 PCDH7 | 1.92e-07 | 777 | 204 | 19 | 35844135 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | HEMGN UBL4A LRRC59 RCC2 GTF3C3 UBC SLC30A9 HSP90AB1 COPA TCOF1 APC NUP214 LTBP1 | 1.97e-07 | 353 | 204 | 13 | 27545878 |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 32751694 | ||
| Pubmed | Structure of tetraubiquitin shows how multiubiquitin chains can be formed. | 1.99e-07 | 3 | 204 | 3 | 8107144 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 1321656 | ||
| Pubmed | CDSN UBL4A LRRC59 UBA52 AHNAK DMD PLS3 AP3D1 HSP90AB1 FLNA COPA TCOF1 MYO18A MACF1 HDLBP | 2.30e-07 | 488 | 204 | 15 | 31324722 | |
| Pubmed | PRPF31 LIN7C SRPK1 CHD1 RCC2 MFF PTPN13 BTF3 USP7 HERC2 PLS3 CNOT11 POLR1A SFSWAP SYNE1 CAMSAP3 NSD1 APC TMX2 SLC12A2 SETD5 PHF3 MDC1 MACF1 EIF3B ZMYM3 HDLBP | 2.33e-07 | 1497 | 204 | 27 | 31527615 | |
| Pubmed | Development and function of innate polyclonal TCRalphabeta+ CD8+ thymocytes. | 2.35e-07 | 10 | 204 | 4 | 21844388 | |
| Pubmed | The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. | 2.35e-07 | 10 | 204 | 4 | 11231585 | |
| Pubmed | 2.35e-07 | 10 | 204 | 4 | 10882101 | ||
| Pubmed | LRRC59 RPS27A UBA52 UBB UBC DMD PZP HSP90AB1 HSPE1 FLNA VPS13B | 2.70e-07 | 247 | 204 | 11 | 30713523 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NOLC1 PRPF31 STYXL2 EHD3 NEK4 PTPN13 AHNAK MINDY4 RAB6A PLS3 PRRC2B HSP90AB3P CNOT11 DNAJC13 ANK3 HSDL2 MYO19 CAMSAP3 XPO4 DZANK1 SETD5 SH3PXD2A PAN3 CDC25C TP53BP1 | 2.81e-07 | 1321 | 204 | 25 | 27173435 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ERBB2 PTPN13 FDXR ALG5 ADAM17 ATP13A3 ALCAM HERC2 HERC1 RAB27B PMPCB SYNE1 MYO18A APC BTAF1 SLC12A2 MACF1 PEAK1 | 2.91e-07 | 719 | 204 | 18 | 35337019 |
| Pubmed | Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV. | 3.19e-07 | 25 | 204 | 5 | 15385968 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 PRPF31 SRPK1 RPS27A ADAR RCC2 ARL6IP4 UBC BTF3 PRRC2B HSP90AB1 FLNA TCOF1 SYNE1 MYO18A UBE2O MACF1 CDK11B HDLBP | 3.42e-07 | 807 | 204 | 19 | 22681889 |
| Pubmed | SRPK1 PFAS RAD54L2 RCC2 LPIN1 GSE1 PZP AP3D1 PRRC2B MIA3 MYO19 CAMSAP3 APC BTAF1 SLC4A2 CHTF18 PAM | 3.45e-07 | 650 | 204 | 17 | 38777146 | |
| Pubmed | Restricted MHC-peptide repertoire predisposes to autoimmunity. | 3.67e-07 | 11 | 204 | 4 | 15998789 | |
| Pubmed | 3.67e-07 | 11 | 204 | 4 | 22522492 | ||
| Pubmed | PRPF31 GAK HLA-A CHD1 NEK4 ALMS1 AGTPBP1 MIA3 POLR1A L3MBTL2 APC NUP214 SLC4A2 UBE2O SLC12A2 PHF3 MDC1 CDK11B | 3.85e-07 | 733 | 204 | 18 | 34672954 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | CDSN SDE2 RAD54L2 UBA52 UBC PIGR AHNAK USP7 HSP90AB1 FLNA TACC2 PHF3 AHNAK2 HDLBP | 4.34e-07 | 444 | 204 | 14 | 34795231 |
| Pubmed | LIN7C HLA-C UBL4A CHD1 LRRC59 RPS27A ADAR UBA52 BTF3 AHNAK USP7 DMD RAB6A HSPE1 COPA CAMSAP3 NUP214 SH3PXD2A TNKS PEAK1 | 5.40e-07 | 916 | 204 | 20 | 32203420 | |
| Pubmed | Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin. | 5.48e-07 | 12 | 204 | 4 | 12150895 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 5.85e-07 | 120 | 204 | 8 | 31413325 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | GAK SRPK1 RCC2 BTF3 AHNAK HERC2 AP3D1 AGTPBP1 SFSWAP COPA TACC2 | 6.29e-07 | 269 | 204 | 11 | 29511261 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 PRPF31 SRPK1 ADAR RCC2 GTF3C3 ARL6IP4 UBC HERC2 AP3D1 AGTPBP1 DNAJC13 POLR1A COPA MYO18A TACC2 PHF3 MACF1 | 6.36e-07 | 759 | 204 | 18 | 35915203 |
| Pubmed | 7.88e-07 | 13 | 204 | 4 | 29084838 | ||
| Pubmed | HLA-A UNC5B SPTBN2 LRRC59 RPS27A RAB6A HSDL2 DNM1L SLC4A2 SLC7A1 SLC12A2 MACF1 PEAK1 PCDH7 | 7.90e-07 | 467 | 204 | 14 | 30194290 | |
| Pubmed | Regulation of follitropin receptor cell surface residency by the ubiquitin-proteasome pathway. | 7.92e-07 | 4 | 204 | 3 | 12960054 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 22285186 | ||
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 12507430 | ||
| Pubmed | Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. | 7.92e-07 | 4 | 204 | 3 | 14506283 | |
| Pubmed | SRPK1 RPS27A ADAR RCC2 GTF3C3 AHNAK USP7 AP3D1 AGTPBP1 HSP90AB1 HSPE1 COPA UBE2O SIRT2 HDLBP | 9.64e-07 | 547 | 204 | 15 | 37267103 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 PRPF31 CHD1 LRRC59 RPS27A ADAR RCC2 UBA52 AHNAK HSP90AB1 FLNA SFSWAP BAZ2B NSD1 NUP214 PHF3 MDC1 CDK11B TP53BP1 HDLBP | 1.01e-06 | 954 | 204 | 20 | 36373674 |
| Pubmed | SRPK1 ADAR RCC2 UBC USP7 ALCAM PLS3 HSP90AB1 FLNA COPA PMPCB SLC4A2 SLC12A2 EIF3B | 1.20e-06 | 484 | 204 | 14 | 31995728 | |
| Pubmed | GTF3C3 PTPN13 GSE1 ALMS1 AHNAK FLNA TSHZ3 DNAJC13 L3MBTL2 CAMSAP3 APC NUP214 ZMYM3 | 1.32e-06 | 418 | 204 | 13 | 34709266 | |
| Pubmed | PRPF31 UBL4A SRPK1 LRRC59 RCC2 GTF3C3 UBB USP7 RAB6A HSP90AB1 TTF2 FLNA UBQLN2 COPA TCOF1 BTAF1 UBE2O KANSL1 EIF3B HDLBP | 1.32e-06 | 971 | 204 | 20 | 33306668 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NOLC1 PRPF31 GTF3C3 PIGR AHNAK HERC2 PLS3 PRRC2B CNOT11 COPA L3MBTL2 SYNE1 APC LAMB1 TACC2 NUP214 KANSL1 EIF3B CDC25C VPS13B ZMYM3 TP53BP1 | 1.38e-06 | 1155 | 204 | 22 | 20360068 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GAK LIN7C SRPK1 PFAS CHD1 RCC2 DMD PLS3 PRRC2B HSP90AB3P FLNA TCOF1 PMPCB LAMB1 XPO4 DNM1L NUP214 UBE2O TNKS CDC25C | 1.39e-06 | 974 | 204 | 20 | 28675297 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ERBB2 HLA-C SPTBN2 LRRC59 UBC AHNAK ADAM17 HSP90AB1 FLNA ANK3 NUP214 SLC12A2 MACF1 PEAK1 HDLBP | 1.44e-06 | 565 | 204 | 15 | 25468996 |
| Interaction | NAA40 interactions | NOLC1 SDE2 GAK PFAS CHD1 LRRC59 RPS27A ADAR RCC2 UBA52 PTPN13 GSE1 ALMS1 BTF3 AHNAK USP7 AP3D1 PRRC2B HSP90AB1 TTF2 FLNA L3MBTL2 TCOF1 DNM1L TACC2 BTAF1 NUP214 UBE2O SIRT2 MACF1 CGNL1 TP53BP1 AHNAK2 HDLBP | 1.56e-10 | 978 | 200 | 34 | int:NAA40 |
| Interaction | TAX1BP1 interactions | HLA-A RPS27A RAD54L2 MFF UBA52 UBB UBC BTF3 PRRC2B HSPE1 TSHZ3 MIA3 DNAJC13 UBQLN2 L3MBTL2 APC NUP214 MDC1 HDLBP | 1.55e-09 | 342 | 200 | 19 | int:TAX1BP1 |
| Interaction | C11orf52 interactions | ERBB2 HLA-A UNC5B SPTBN2 SRPK1 UBA52 PTPN13 ATP13A3 ALCAM ANK3 SLC4A2 SIRT2 SLC12A2 MACF1 PEAK1 PCDH7 | 9.26e-08 | 311 | 200 | 16 | int:C11orf52 |
| Interaction | ZFPL1 interactions | HLA-A UNC5B SPTBN2 MFF UBA52 PTPN13 MIP ATP13A3 ANK3 COPA APC DNM1L CREB3L1 SLC4A2 SLC12A2 PEAK1 PCDH7 VPS13B AHNAK2 | 1.18e-07 | 448 | 200 | 19 | int:ZFPL1 |
| Interaction | LAMP1 interactions | LIN7C HLA-A HLA-C UNC5B SPTBN2 UBL4A LRRC59 PLEKHM1 UBA52 PTPN13 ALG5 ATP13A3 RAB6A AP3D1 UBQLN2 MYO18A SLC4A2 SLC12A2 MACF1 PEAK1 PCDH7 AHNAK2 HDLBP | 1.18e-07 | 644 | 200 | 23 | int:LAMP1 |
| Interaction | RNF11 interactions | LRRC59 RPS27A UBA52 UBB USP7 HERC2 DMD HERC1 RAB6A UBQLN2 UBE2O SPRTN | 1.28e-07 | 169 | 200 | 12 | int:RNF11 |
| Interaction | GJD3 interactions | HLA-A HLA-C UNC5B SPTBN2 LRRC59 UBA52 PTPN13 ATP13A3 ALCAM SLC30A9 RAB6A MIA3 COPA SYNE1 SLC4A2 SLC12A2 PEAK1 PCDH7 VPS13B | 1.45e-07 | 454 | 200 | 19 | int:GJD3 |
| Interaction | HERC2 interactions | GAK HLA-A SRPK1 NEK4 UBC BTF3 HERC2 HERC1 SLC30A9 AP3D1 SFSWAP COPA HSDL2 NSD1 MDC1 MACF1 EIF3B CDC25C TP53BP1 HDLBP | 1.53e-07 | 503 | 200 | 20 | int:HERC2 |
| Interaction | H2BC13 interactions | NOLC1 RPS27A ARL6IP4 UBA52 UBB BTF3 ALG5 HERC1 HSP90AB1 TCOF1 KIF21A PCLO SPRTN | 1.88e-07 | 210 | 200 | 13 | int:H2BC13 |
| Interaction | DIRAS3 interactions | HLA-A SPTBN2 LRRC59 PTPN13 ALCAM HERC1 ANK3 APC SLC7A1 SLC12A2 FEZ2 MACF1 PEAK1 PCDH7 | 3.83e-07 | 262 | 200 | 14 | int:DIRAS3 |
| Interaction | SIRT7 interactions | NOLC1 SPTBN2 SRPK1 PFAS CHD1 RCC2 GTF3C3 AHNAK USP7 HERC2 PRRC2B FLNA POLR1A COPA TCOF1 NSD1 NUP214 UBE2O PHF3 MDC1 MACF1 ZMYM3 TP53BP1 HDLBP | 3.97e-07 | 744 | 200 | 24 | int:SIRT7 |
| Interaction | H3-4 interactions | CHD1 RPS27A RCC2 UBA52 UBB BTF3 AHNAK TAF4B HERC2 DMD HSP90AB1 RAG1 L3MBTL2 KIF21A NSD1 PHF3 VPS13B MYB | 5.69e-07 | 448 | 200 | 18 | int:H3-4 |
| Interaction | LMBR1L interactions | SDE2 HLA-A HLA-C UBL4A LRRC59 GTF3C3 ALG5 SLC30A9 RAB6A HSP90AB1 TTF2 FLNA MIA3 UBQLN2 POLR1A COPA TCOF1 HSDL2 DNAH2 BTAF1 NUP214 SLC4A2 SLC7A1 UBE2O SLC12A2 ZMYM3 HDLBP | 7.82e-07 | 946 | 200 | 27 | int:LMBR1L |
| Interaction | TEDC2 interactions | RPS27A UBA52 UBB UBC PTPN13 AHNAK HSP90AB1 HSPE1 LAMB1 FEZ2 CHTF18 LTBP1 | 1.08e-06 | 206 | 200 | 12 | int:TEDC2 |
| Interaction | PSMD14 interactions | PRPF31 UBL4A RPS27A MFF UBA52 UBB UBC HERC2 HERC1 PLS3 HSP90AB1 HSPE1 FLNA UBQLN2 PCLO PCDH11Y SPRTN TP53BP1 AHNAK2 | 1.38e-06 | 527 | 200 | 19 | int:PSMD14 |
| Interaction | MECP2 interactions | NOLC1 PRPF31 CDSN SPTBN2 LRRC59 RPS27A ZSCAN25 ADAR RCC2 GTF3C3 PTPN13 BTF3 USP7 PZP AP3D1 HSP90AB1 HSPE1 DNAJC13 SFSWAP COPA TCOF1 SYNE1 MYO18A NSD1 APC HS1BP3 MACF1 EIF3B CDK11B PAN3 ZMYM3 TP53BP1 | 1.39e-06 | 1287 | 200 | 32 | int:MECP2 |
| Interaction | STX4 interactions | HLA-A HLA-C UNC5B UBL4A FAXDC2 LRRC59 UBA52 MIA3 ANK3 COPA SYNE1 APC SLC4A2 SLC7A1 SLC12A2 PEAK1 PCDH7 | 1.39e-06 | 428 | 200 | 17 | int:STX4 |
| Interaction | PABPC1 interactions | ERBB2 UBL4A SRPK1 PFAS LRRC59 RCC2 UBC BTF3 AHNAK USP7 HERC2 PLS3 PRRC2B FLNA UBQLN2 NSD1 DNM1L TDRD7 EIF3B PAN3 PCDH7 HDLBP | 1.87e-06 | 699 | 200 | 22 | int:PABPC1 |
| Interaction | KCNA3 interactions | ERBB2 HLA-A UNC5B LRRC59 RCC2 EHD3 PTPN13 AHNAK PLS3 AP3D1 HSP90AB1 TTF2 ANK3 COPA TCOF1 MYO18A APC DNM1L NUP214 PHF3 MACF1 RIMS1 PEAK1 PCDH7 HDLBP | 1.88e-06 | 871 | 200 | 25 | int:KCNA3 |
| Interaction | EBAG9 interactions | GAK HLA-A HLA-C UNC5B CFHR5 UBA52 PTPN13 ANK3 COPA SIRT2 SLC12A2 PEAK1 PCDH7 VPS13B | 2.16e-06 | 303 | 200 | 14 | int:EBAG9 |
| Interaction | PARP1 interactions | NOLC1 PRPF31 ERBB2 GAK CHD1 RPS27A ADAR GTF3C3 ARL6IP4 NEK4 UBC PTPN13 BTF3 USP7 AP3D1 HSP90AB1 POLR1A L3MBTL2 NSD1 DNM1L BTAF1 UBE2O SIRT2 THRB PHF3 CGNL1 SPRTN TDP1 ZMYM3 TP53BP1 MYB HDLBP | 2.23e-06 | 1316 | 200 | 32 | int:PARP1 |
| Interaction | STX6 interactions | ERBB2 GAK HLA-A UNC5B LRRC59 GTF3C3 PTPN13 FCER1A AP3D1 MIA3 ANK3 SLC12A2 MACF1 PEAK1 PCDH7 VPS13B AHNAK2 | 2.58e-06 | 448 | 200 | 17 | int:STX6 |
| Interaction | UIMC1 interactions | 3.38e-06 | 121 | 200 | 9 | int:UIMC1 | |
| Interaction | H3C1 interactions | SRPK1 CHD1 LRRC59 RPS27A RCC2 GTF3C3 UBA52 UBB BTF3 AHNAK ALG5 USP7 HSPE1 RAG1 ANK3 L3MBTL2 SYNE1 DNAH2 MYO18A NSD1 SIRT2 PHF3 MDC1 TP53BP1 MYB | 3.43e-06 | 901 | 200 | 25 | int:H3C1 |
| Interaction | NUP43 interactions | CHD1 CLSTN2 RAD54L2 RCC2 ARL6IP4 GSE1 HSP90AB1 FLNA L3MBTL2 HSDL2 BAZ2B NSD1 APC NUP214 TDRD7 KANSL1 MDC1 CDK11B ZMYM3 AHNAK2 | 4.43e-06 | 625 | 200 | 20 | int:NUP43 |
| Interaction | C2CD4B interactions | 4.57e-06 | 44 | 200 | 6 | int:C2CD4B | |
| Interaction | CAPZB interactions | GAK LIN7C CHD1 LRRC59 RPS27A ADAR RCC2 BTF3 USP7 PLS3 AGTPBP1 HSP90AB1 HSPE1 FLNA CNOT11 POLR1A COPA HSDL2 MYO19 MYO18A TACC2 NUP214 UBE2O MDC1 EIF3B PEAK1 TP53BP1 | 5.45e-06 | 1049 | 200 | 27 | int:CAPZB |
| Interaction | KIF20A interactions | NOLC1 SPTBN2 CHD1 ADAR ARL6IP4 LPIN1 ALMS1 AHNAK HERC2 HERC1 RAB6A PRRC2B HSP90AB1 ANKRD35 FLNA SFSWAP COPA HSDL2 SYNE1 PCLO MYO18A THRB MDC1 MACF1 TNKS PAN3 AHNAK2 | 5.75e-06 | 1052 | 200 | 27 | int:KIF20A |
| Interaction | EED interactions | NOLC1 GAK RPS27A ADAR GTF3C3 PIGR USP7 ADAM17 HERC2 PLS3 AP3D1 HSP90AB1 FLNA COPA L3MBTL2 TCOF1 BAZ2B MYO19 MYO18A NSD1 LAMB1 XPO4 DNM1L NUP214 HS1BP3 TMX2 SIRT2 MDC1 MACF1 EIF3B CGNL1 TP53BP1 HDLBP | 5.80e-06 | 1445 | 200 | 33 | int:EED |
| Interaction | DNAJC5 interactions | LIN7C HLA-A UNC5B SPTBN2 PTPN13 AP3D1 PRRC2B ANK3 L3MBTL2 MYO18A SLC4A2 SLC12A2 MACF1 PEAK1 PCDH7 | 5.98e-06 | 378 | 200 | 15 | int:DNAJC5 |
| Interaction | H2BC5 interactions | NOLC1 RPS27A GALNT16 UBA52 UBB BTF3 ALG5 HERC1 UBQLN2 PCDHGC5 TCOF1 PCDHGA1 PCLO SPRTN | 5.99e-06 | 331 | 200 | 14 | int:H2BC5 |
| Interaction | GJA1 interactions | ERBB2 HLA-A UNC5B LRRC59 UBA52 PTPN13 USP7 ATP13A3 FLNA MIA3 ANK3 COPA APC SLC4A2 SLC12A2 MACF1 PEAK1 PCDH7 VPS13B | 5.99e-06 | 583 | 200 | 19 | int:GJA1 |
| Interaction | CIT interactions | NOLC1 PRPF31 HLA-C SPTBN2 PIH1D2 SRPK1 PFAS CHD1 LRRC59 RPS27A ADAR ALMS1 BTF3 AHNAK HERC1 PLS3 HSP90AB1 HSP90AB3P ANKRD35 RAG1 FLNA POLR1A COPA TCOF1 SYNE1 PCLO MYO18A SETD5 MDC1 MACF1 EIF3B AHNAK2 HDLBP | 6.24e-06 | 1450 | 200 | 33 | int:CIT |
| Interaction | PML interactions | NOLC1 CDSN SDE2 RPS27A RAD54L2 GTF3C3 NEK4 UBA52 UBC PIGR AHNAK USP7 PLAGL1 AP3D1 HSP90AB1 FLNA TACC2 PHF3 CHTF18 MDC1 ZMYM3 TP53BP1 MYB AHNAK2 HDLBP | 6.31e-06 | 933 | 200 | 25 | int:PML |
| Interaction | ENO1 interactions | HEMGN EHD3 NEK4 BTF3 AHNAK ANKRD40 AGTPBP1 HSP90AB1 HSPE1 UBQLN2 POLR1A ANK3 HSDL2 PMPCB MYO18A TDRD7 MDC1 SPRTN PCDH7 TP53BP1 HDLBP | 6.97e-06 | 701 | 200 | 21 | int:ENO1 |
| Interaction | MEX3A interactions | ZC3H11B ADAR AHNAK PRRC2B HSP90AB1 FLNA COPA L3MBTL2 TENT5A NSD1 SETD5 MACF1 EIF3B SPRTN AHNAK2 | 7.23e-06 | 384 | 200 | 15 | int:MEX3A |
| Interaction | KCTD13 interactions | GAK SPTBN2 LRRC59 EHD3 C12orf50 USP7 DMD PLS3 AP3D1 AGTPBP1 PRRC2B HSP90AB1 FLNA DNAJC13 ANK3 COPA SYNE1 PCLO CAMSAP3 MYO18A APC DNM1L CYRIB DZANK1 UBE2O SIRT2 MACF1 RIMS1 CGNL1 PEAK1 SPRTN HDLBP | 7.39e-06 | 1394 | 200 | 32 | int:KCTD13 |
| Interaction | SYK interactions | NOLC1 ERBB2 SRPK1 GTF3C3 UBB FCER1A BTF3 ALCAM FLNA TCOF1 TENT5A NUP214 | 8.29e-06 | 251 | 200 | 12 | int:SYK |
| Interaction | HSD17B11 interactions | HLA-A HLA-C LRRC59 UBA52 ADAM17 SLC30A9 MIA3 COPA SYNE1 TACC2 SLC4A2 TMX2 SIRT2 SLC12A2 SPRTN | 8.69e-06 | 390 | 200 | 15 | int:HSD17B11 |
| Interaction | TXNIP interactions | PRPF31 GTF3C3 UBA52 AHNAK HERC2 PLS3 HSP90AB1 FLNA COPA PMPCB UBE2O | 9.22e-06 | 212 | 200 | 11 | int:TXNIP |
| Interaction | MARCKS interactions | HLA-A HLA-C UNC5B SPTBN2 LRRC59 PTPN13 ATP13A3 DMD RAB6A HSPE1 UBQLN2 ANK3 SLC7A1 SIRT2 SLC12A2 MACF1 PEAK1 PCDH7 HDLBP | 9.22e-06 | 601 | 200 | 19 | int:MARCKS |
| Interaction | MMEL1 interactions | 9.49e-06 | 5 | 200 | 3 | int:MMEL1 | |
| Interaction | STX7 interactions | HLA-A HLA-C UNC5B UBL4A LRRC59 PLEKHM1 MFF EHD3 UBA52 ATP13A3 ALCAM MIA3 ANK3 CREB3L1 SLC4A2 TMX2 SLC7A1 SLC12A2 PEAK1 PCDH7 | 9.66e-06 | 659 | 200 | 20 | int:STX7 |
| Interaction | OBSL1 interactions | NOLC1 PRPF31 SPTBN2 CHD1 LRRC59 ADAR RCC2 AHNAK HERC2 AGTPBP1 HSP90AB1 FLNA DNAJC13 POLR1A COPA TCOF1 SYNE1 PCLO LAMB1 NUP214 SLC12A2 MDC1 MACF1 HDLBP | 1.10e-05 | 902 | 200 | 24 | int:OBSL1 |
| Interaction | BCAP31 interactions | NOLC1 HLA-A HLA-C UBL4A LRRC59 UBB ADAM17 SLC30A9 RAB6A AP3D1 HSP90AB1 MIA3 COPA TCOF1 BAZ2B SLC4A2 SLC7A1 SLC12A2 | 1.11e-05 | 554 | 200 | 18 | int:BCAP31 |
| Interaction | CLTA interactions | GAK RPS27A ALMS1 BTF3 HERC2 AP3D1 HSP90AB3P FLNA MIA3 POLR1A MYO19 MYO18A AHNAK2 HDLBP | 1.16e-05 | 351 | 200 | 14 | int:CLTA |
| Interaction | YAP1 interactions | LIN7C SPTBN2 CHD1 LRRC59 ADAR GTF3C3 UBA52 PTPN13 BTF3 AHNAK USP7 PLS3 HSP90AB1 HSP90AB3P TTF2 FLNA UBQLN2 ANK3 COPA TCOF1 NSD1 UBE2O SIRT2 PHF3 MDC1 EIF3B HDLBP | 1.19e-05 | 1095 | 200 | 27 | int:YAP1 |
| Interaction | RAB4A interactions | GAK HLA-A LRRC59 RCC2 ATP13A3 AP3D1 DOP1B MIA3 DNAJC13 SYNE1 DNM1L SLC7A1 SLC12A2 PEAK1 VPS13B AHNAK2 | 1.40e-05 | 457 | 200 | 16 | int:RAB4A |
| Interaction | NINL interactions | ERBB2 ARL6IP4 PTPN13 GSE1 ALMS1 PIGR USP7 PLS3 PRRC2B HSPE1 TTF2 CAMSAP3 KANSL1 LTBP1 CGNL1 PAN3 | 1.44e-05 | 458 | 200 | 16 | int:NINL |
| Interaction | GOLGA1 interactions | 1.51e-05 | 183 | 200 | 10 | int:GOLGA1 | |
| Interaction | HECTD1 interactions | NOLC1 PRPF31 SRPK1 ADAR RCC2 GTF3C3 ARL6IP4 NEK4 UBA52 UBC HERC2 AP3D1 AGTPBP1 HSP90AB1 DNAJC13 POLR1A SFSWAP COPA MYO18A APC TACC2 SH3PXD2A PHF3 MACF1 CDC25C | 1.56e-05 | 984 | 200 | 25 | int:HECTD1 |
| Interaction | SLX4 interactions | CDSN CHD1 RPS27A RAD54L2 ADAR RCC2 GTF3C3 UBC PRRC2B HSP90AB1 FLNA PMPCB BAZ2B NUP214 MDC1 SPRTN TP53BP1 HDLBP | 1.70e-05 | 572 | 200 | 18 | int:SLX4 |
| Interaction | RAB35 interactions | ERBB2 HLA-A UNC5B SPTBN2 UBL4A LRRC59 UBA52 PTPN13 ATP13A3 ALCAM ANK3 APC SLC4A2 SLC7A1 SLC12A2 MACF1 PEAK1 PCDH7 | 1.74e-05 | 573 | 200 | 18 | int:RAB35 |
| Interaction | YWHAZ interactions | NOLC1 PRPF31 ERBB2 CDSN SPTBN2 PFAS MFF NEK4 UBB PTPN13 BTF3 HERC2 ANKRD40 HSP90AB1 COL6A6 CAMSAP3 MYO18A APC DNM1L TACC2 SH3PXD2A PHF3 MDC1 MACF1 CDK11B CGNL1 PEAK1 CDC25C PCDH7 TP53BP1 | 1.77e-05 | 1319 | 200 | 30 | int:YWHAZ |
| Interaction | NUMA1 interactions | LRRC59 RPS27A ADAR RCC2 PIGR BTF3 USP7 HSP90AB1 DNAH2 NUP214 MDC1 MACF1 TNKS ZMYM3 TP53BP1 HDLBP | 1.92e-05 | 469 | 200 | 16 | int:NUMA1 |
| Interaction | BUB3 interactions | UBB BTF3 USP7 HERC2 UBQLN2 APC DNM1L UBE2O KANSL1 TP53BP1 HDLBP | 2.14e-05 | 232 | 200 | 11 | int:BUB3 |
| Interaction | MAPK6 interactions | HLA-A HLA-C UBL4A RPS27A PLEKHM1 MFF UBA52 HERC2 AP3D1 HSP90AB1 POLR1A ANK3 HSDL2 CYRIB SLC7A1 UBE2O | 2.19e-05 | 474 | 200 | 16 | int:MAPK6 |
| Interaction | RACK1 interactions | PRPF31 ERBB2 GAK UBL4A SRPK1 LRRC59 RPS27A ADAR NEK4 BTF3 PRRC2B ANKRD35 SLC6A3 UBE2O MDC1 EIF3B SPRTN PCDH7 TP53BP1 HDLBP | 2.50e-05 | 704 | 200 | 20 | int:RACK1 |
| Interaction | FGF12 interactions | 2.55e-05 | 87 | 200 | 7 | int:FGF12 | |
| Interaction | PXMP2 interactions | HLA-C UBL4A LRRC59 MFF UBA52 ATP13A3 HERC1 SLC30A9 RAB6A MIA3 DNM1L SLC12A2 | 2.55e-05 | 281 | 200 | 12 | int:PXMP2 |
| Interaction | SUMO2 interactions | RAD54L2 UBB AHNAK USP7 HSP90AB1 ANKRD35 HSPE1 FLNA COPA DNM1L NUP214 PHF3 MDC1 ZMYM3 TP53BP1 MYB AHNAK2 HDLBP | 2.62e-05 | 591 | 200 | 18 | int:SUMO2 |
| Interaction | ITPRID2 interactions | 2.66e-05 | 120 | 200 | 8 | int:ITPRID2 | |
| Interaction | FMR1 interactions | ADAR EHD3 SUOX BTF3 AHNAK USP7 HERC2 PRRC2B MIA3 TCOF1 APC TACC2 ZFPM2 DZANK1 MACF1 TP53BP1 HDLBP | 2.66e-05 | 536 | 200 | 17 | int:FMR1 |
| Interaction | NBR1 interactions | GAK HLA-A UBB UBC BTF3 PLS3 HSP90AB1 FLNA UBQLN2 TCOF1 HAP1 DNM1L UBE2O MACF1 | 2.81e-05 | 380 | 200 | 14 | int:NBR1 |
| Interaction | TNIK interactions | SPTBN2 GSE1 HERC2 AGTPBP1 PRRC2B ANK3 SYNE1 APC DZANK1 MACF1 TNKS RIMS1 TP53BP1 HDLBP | 2.89e-05 | 381 | 200 | 14 | int:TNIK |
| Interaction | STON2 interactions | 2.96e-05 | 89 | 200 | 7 | int:STON2 | |
| Interaction | CALCOCO2 interactions | PRPF31 LIN7C SPTBN2 RPS27A ENKD1 UBA52 UBB BTF3 BEX2 HSP90AB1 UBQLN2 COPA MYO18A DNM1L KANSL1 SETD5 | 2.96e-05 | 486 | 200 | 16 | int:CALCOCO2 |
| Interaction | USP14 interactions | SPTBN2 PFAS RPS27A UBB UBC AHNAK USP7 PLS3 FLNA COPA MYO18A MDC1 MACF1 ZMYM3 AHNAK2 HDLBP | 3.19e-05 | 489 | 200 | 16 | int:USP14 |
| Interaction | LYN interactions | ERBB2 HLA-A UNC5B SPTBN2 UBA52 UBB PTPN13 BTF3 ATP13A3 DMD HSP90AB1 HSP90AB3P POLR1A ANK3 APC SLC12A2 MACF1 PEAK1 PCDH7 AHNAK2 | 3.43e-05 | 720 | 200 | 20 | int:LYN |
| Interaction | ATXN3 interactions | HLA-A UBL4A UBB UBC USP7 HSP90AB1 HSPE1 FLNA COPA HSDL2 HAP1 CAMSAP3 DNM1L MDC1 SPRTN | 3.46e-05 | 439 | 200 | 15 | int:ATXN3 |
| Interaction | GPRASP3 interactions | 3.76e-05 | 63 | 200 | 6 | int:GPRASP3 | |
| Interaction | SYNE3 interactions | GAK HLA-C UBB GSE1 ALMS1 PRRC2B MIA3 COPA CAMSAP3 APC LAMB1 NUP214 MACF1 CGNL1 PAN3 | 3.94e-05 | 444 | 200 | 15 | int:SYNE3 |
| Interaction | EFTUD2 interactions | NOLC1 PRPF31 SRPK1 PFAS CHD1 LRRC59 RPS27A RCC2 ARL6IP4 NEK4 BTF3 AHNAK USP7 PLS3 AP3D1 HSP90AB1 FLNA CNOT11 COPA TCOF1 HSDL2 KIF21A TACC2 UBE2O CHTF18 MDC1 MACF1 EIF3B SPRTN AHNAK2 HDLBP | 4.08e-05 | 1449 | 200 | 31 | int:EFTUD2 |
| Interaction | EIF3F interactions | CDSN SUOX BTF3 HERC2 PRRC2B HSP90AB1 FLNA UBQLN2 ANK3 DNM1L EIF3B CDK11B | 4.24e-05 | 296 | 200 | 12 | int:EIF3F |
| Interaction | BAP1 interactions | PRPF31 LIN7C SPTBN2 PFAS LRRC59 RPS27A ADAR RCC2 GTF3C3 BTF3 AHNAK USP7 PLS3 AP3D1 HSP90AB1 HSPE1 FLNA ANK3 COPA L3MBTL2 TCOF1 CAMSAP3 MYO18A DNM1L UBE2O MACF1 EIF3B MYB HDLBP | 4.28e-05 | 1314 | 200 | 29 | int:BAP1 |
| Interaction | TUBB4B interactions | UBL4A NEK4 UBC ALMS1 BTF3 FDXR HERC2 HSP90AB1 UBQLN2 CAMSAP3 APC TACC2 NUP214 UBE2O THRB SPRTN PCDH7 | 4.61e-05 | 560 | 200 | 17 | int:TUBB4B |
| Interaction | YWHAE interactions | NOLC1 PRPF31 UBL4A ENKD1 NEK4 LPIN1 PTPN13 BTF3 MINDY4 RAB6A HSP90AB1 FLNA COPA CAMSAP3 APC DNM1L TACC2 UBE2O SH3PXD2A MACF1 LTBP1 CDK11B CGNL1 PEAK1 SPRTN CDC25C PCDH7 HDLBP | 4.94e-05 | 1256 | 200 | 28 | int:YWHAE |
| Interaction | PFN1 interactions | SRPK1 UBB ALMS1 BTF3 DOP1B HSP90AB1 HSPE1 TTF2 DNAJC13 PCLO APC DNM1L MACF1 PEAK1 TP53BP1 AHNAK2 | 5.14e-05 | 509 | 200 | 16 | int:PFN1 |
| Interaction | BRAF interactions | RPS27A UBA52 UBB USP7 HSP90AB1 HSP90AB3P DNAJC13 COPA MDC1 HDLBP | 5.32e-05 | 212 | 200 | 10 | int:BRAF |
| Interaction | HDAC4 interactions | RPS27A RCC2 BTF3 HERC2 AP3D1 PRRC2B HSP90AB1 COPA HAP1 CAMSAP3 APC NUP214 FRY KANSL1 SH3PXD2A TNKS EIF3B CDC25C TP53BP1 HDLBP | 5.41e-05 | 744 | 200 | 20 | int:HDAC4 |
| Interaction | RAD18 interactions | NOLC1 PRPF31 LIN7C SRPK1 CHD1 RCC2 ARL6IP4 UBB UBC USP7 SFSWAP CDK11B SPRTN ZMYM3 TP53BP1 | 5.46e-05 | 457 | 200 | 15 | int:RAD18 |
| Interaction | ARRB1 interactions | NOLC1 CHD1 RPS27A UBA52 UBB DMD AP3D1 FLNA POLR1A TCOF1 TP53BP1 HDLBP | 5.48e-05 | 304 | 200 | 12 | int:ARRB1 |
| Interaction | CHMP4C interactions | NOLC1 SPTBN2 CHD1 LRRC59 RPS27A ADAR AHNAK HSP90AB1 HSP90AB3P FLNA COPA BAZ2B MYO18A DNM1L CYRIB MDC1 MACF1 LTBP1 EIF3B | 5.75e-05 | 687 | 200 | 19 | int:CHMP4C |
| Interaction | RHOA interactions | HLA-A HLA-C UNC5B SPTBN2 LRRC59 RPS27A MFF PTPN13 ALG5 ATP13A3 SLC30A9 ELMOD1 HSPE1 FLNA MIA3 UBQLN2 ANK3 HSDL2 MYO19 MYO18A SLC4A2 SLC7A1 SLC12A2 MACF1 PEAK1 PCDH7 VPS13B | 5.76e-05 | 1199 | 200 | 27 | int:RHOA |
| Interaction | LCK interactions | NOLC1 ERBB2 SPTBN2 PTPN13 ASB9 USP7 AP3D1 HSP90AB1 HSP90AB3P ANK3 SLC12A2 MACF1 PEAK1 CDC25C AHNAK2 | 6.33e-05 | 463 | 200 | 15 | int:LCK |
| Interaction | ACTC1 interactions | NOLC1 PRPF31 FBXO40 UBL4A RCC2 NEK4 TMCC2 USP7 DMD PLS3 FLNA TCOF1 SYNE1 DNM1L UBE2O PHF3 MDC1 EIF3B TP53BP1 | 6.58e-05 | 694 | 200 | 19 | int:ACTC1 |
| Interaction | CIBAR1 interactions | 6.85e-05 | 137 | 200 | 8 | int:CIBAR1 | |
| Interaction | INSIG2 interactions | 7.10e-05 | 177 | 200 | 9 | int:INSIG2 | |
| Interaction | DNAJB2 interactions | 7.11e-05 | 102 | 200 | 7 | int:DNAJB2 | |
| Interaction | TNIP1 interactions | NOLC1 CDSN HLA-C SPTBN2 LRRC59 RPS27A ADAR RCC2 UBA52 UBC PIGR BTF3 AHNAK USP7 DMD AP3D1 HSP90AB1 TTF2 FLNA POLR1A COPA TCOF1 SYNE1 MYO18A MDC1 EIF3B CDK11B | 7.41e-05 | 1217 | 200 | 27 | int:TNIP1 |
| Interaction | TMPO interactions | NOLC1 CHD1 LRRC59 ADAR NEK4 BTF3 AHNAK USP7 HSP90AB1 FLNA MIA3 UBQLN2 COPA MYO18A TACC2 UBE2O EIF3B SPRTN TP53BP1 HDLBP | 7.51e-05 | 762 | 200 | 20 | int:TMPO |
| Interaction | ARF6 interactions | HLA-A UNC5B SPTBN2 LRRC59 UBA52 AHNAK ATP13A3 ALCAM DMD SLC30A9 AP3D1 ANK3 SLC4A2 SLC7A1 SLC12A2 PEAK1 PCDH7 | 7.71e-05 | 584 | 200 | 17 | int:ARF6 |
| Interaction | KBTBD4 interactions | PRPF31 LIN7C PFAS RPS27A BTF3 AHNAK USP7 ANKRD40 FLNA MIA3 LAMB1 HDLBP | 7.93e-05 | 316 | 200 | 12 | int:KBTBD4 |
| Interaction | EPB41L4A interactions | 7.98e-05 | 140 | 200 | 8 | int:EPB41L4A | |
| Interaction | ANXA2 interactions | CDSN SAMD12 UBA52 ASB9 BTF3 AHNAK FLNA UBQLN2 MYO19 MYO18A CHTF18 SPRTN PCDH7 AHNAK2 | 8.05e-05 | 419 | 200 | 14 | int:ANXA2 |
| Interaction | HMGA1 interactions | HEMGN CHD1 RPS27A UBA52 UBB BTF3 USP7 PCLO NSD1 UBE2O PHF3 MDC1 ZMYM3 CFAP46 | 8.05e-05 | 419 | 200 | 14 | int:HMGA1 |
| Interaction | RAB5A interactions | PRPF31 HLA-A UNC5B PFAS LRRC59 ATP13A3 ALCAM HERC2 RAB6A DOP1B MIA3 CAMSAP3 DNM1L SLC12A2 MACF1 EIF3B PEAK1 VPS13B HDLBP | 8.25e-05 | 706 | 200 | 19 | int:RAB5A |
| Interaction | IMPDH2 interactions | GAK RCC2 UBB ALMS1 BTF3 AGTPBP1 TTF2 FLNA UBQLN2 KIF21A DNM1L UBE2O MDC1 STKLD1 | 8.25e-05 | 420 | 200 | 14 | int:IMPDH2 |
| Interaction | LGALS9 interactions | SRPK1 ADAR RCC2 USP7 ATP13A3 ALCAM PLS3 HSP90AB1 FLNA DNAJC13 COPA PMPCB LAMB1 SLC4A2 SLC7A1 SLC12A2 EIF3B | 8.38e-05 | 588 | 200 | 17 | int:LGALS9 |
| Interaction | EEF2 interactions | UBL4A PFAS LRRC59 RPS27A NEK4 UBA52 BTF3 AHNAK HSP90AB1 ANKRD35 DPH2 FLNA UBQLN2 DNM1L MACF1 SPRTN PCDH7 | 8.38e-05 | 588 | 200 | 17 | int:EEF2 |
| GeneFamily | PDZ domain containing | 1.27e-05 | 152 | 128 | 8 | 1220 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 5.28e-07 | 39 | 203 | 6 | MM3725 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CHD1 NEK4 PTPN13 GSE1 USP7 ADAM17 ATP13A3 ALCAM DMD RAB6A DOP1B DNAJC13 BAZ2B APC BTAF1 TDRD7 SLC7A1 PHF3 MACF1 TNKS VPS13B TP53BP1 | 9.35e-07 | 856 | 203 | 22 | M4500 |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP | 3.73e-06 | 199 | 203 | 10 | M3439 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 3.83e-06 | 31 | 203 | 5 | MM3729 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | LPIN1 AJAP1 GSE1 HERC1 BEX2 AGTPBP1 PRRC2B DOP1B MIA3 UBQLN2 ANK3 COL6A6 KIF21A PCLO APC ZFPM2 FRY SH3PXD2A TNKS RIMS1 FRMPD3 PCDH7 CDH8 AHNAK2 | 5.51e-06 | 1106 | 203 | 24 | M39071 |
| Coexpression | GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN | 9.55e-06 | 175 | 203 | 9 | M7101 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.23e-05 | 39 | 203 | 5 | MM3758 | |
| Coexpression | WELCSH_BRCA1_TARGETS_DN | 1.48e-05 | 141 | 203 | 8 | M2428 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 1.49e-05 | 102 | 203 | 7 | M5601 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 2.25e-05 | 44 | 203 | 5 | MM3775 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 2.66e-05 | 199 | 203 | 9 | M6264 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 3.89e-05 | 25 | 203 | 4 | MM672 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING | 4.28e-05 | 120 | 203 | 7 | MM3710 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 6.27e-05 | 276 | 203 | 10 | M3063 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 8.01e-05 | 57 | 203 | 5 | MM3716 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | NOLC1 BCAT1 LRRC59 POLR1A KIF21A XPO4 BTAF1 SLC12A2 SH3PXD2A LTBP1 EIF3B CGNL1 | 8.77e-05 | 408 | 203 | 12 | M11891 |
| Coexpression | LIAO_METASTASIS | PRPF31 BCAT1 RCC2 PLAGL1 PRRC2B FLNA LAMB1 DNM1L CREB3L1 UBE2O CHTF18 LRP11 PAM ZMYM3 | 8.80e-05 | 540 | 203 | 14 | M13809 |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | NOLC1 BCAT1 LRRC59 POLR1A KIF21A XPO4 BTAF1 SLC12A2 SH3PXD2A LTBP1 EIF3B CGNL1 | 1.03e-04 | 415 | 203 | 12 | MM1028 |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 1.10e-04 | 97 | 203 | 6 | MM3789 | |
| Coexpression | BUSSLINGER_GASTRIC_G_CELLS | 1.17e-04 | 98 | 203 | 6 | M40018 | |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | PIH1D2 EFHB ENKD1 NEK4 UBB CFAP54 ALMS1 EFCAB12 FDXR DMD PZP WDR49 SYNE1 KIF21A DNAH2 DZANK1 LRP11 TP53BP1 CFAP46 MYB AHNAK2 | 1.25e-04 | 1093 | 203 | 21 | M41649 |
| Coexpression | GSE12366_GC_BCELL_VS_PLASMA_CELL_DN | 1.42e-04 | 194 | 203 | 8 | M3167 | |
| Coexpression | GSE3982_NKCELL_VS_TH1_UP | 1.47e-04 | 195 | 203 | 8 | M5593 | |
| Coexpression | GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN | 1.52e-04 | 196 | 203 | 8 | M4676 | |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN | 1.52e-04 | 196 | 203 | 8 | M7124 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN | 1.52e-04 | 196 | 203 | 8 | M4190 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 1.69e-04 | 199 | 203 | 8 | M9124 | |
| Coexpression | BUSSLINGER_GASTRIC_NECK_CELLS | 1.69e-04 | 36 | 203 | 4 | M40008 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP | 1.75e-04 | 200 | 203 | 8 | M8972 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN | 1.75e-04 | 200 | 203 | 8 | M6789 | |
| Coexpression | GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN | 1.75e-04 | 200 | 203 | 8 | M4410 | |
| Coexpression | LEE_BMP2_TARGETS_UP | HLA-A HLA-C SLCO2B1 HLA-H BCAT1 IRAG1 PIGR ALCAM MINDY4 BEX2 ANK3 PAM LTBP1 RIMS1 CGNL1 VPS13B AHNAK2 | 1.90e-04 | 805 | 203 | 17 | MM1067 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_T_CELL_AGEING | HLA-A HLA-C HLA-H UBL4A CHD1 GTF3C3 AHNAK ALG5 TAF4B PRRC2B TMX2 TNKS | 1.97e-04 | 445 | 203 | 12 | MM3853 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | NOLC1 PRPF31 BCAT1 PFAS RPS27A ADAR AJAP1 SASH3 BTF3 ADAM17 TAF4B DPH2 TTF2 DNAJC13 TCOF1 APC BTAF1 NUP214 SLC7A1 PHF3 TNKS RIMS1 CDK11B CDH8 | 2.14e-04 | 1394 | 203 | 24 | M9585 |
| Coexpression | JAATINEN_HEMATOPOIETIC_STEM_CELL_UP | 2.26e-04 | 323 | 203 | 10 | M15107 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | HLA-A HLA-C HLA-H CHD1 RPS27A ADAR LPIN1 UBA52 UBC SASH3 BTF3 AHNAK HERC1 PRRC2B FLNA SYNE1 NSD1 XPO4 BTAF1 CYRIB KANSL1 SETD5 PHF3 MACF1 VPS13B | 2.37e-04 | 1492 | 203 | 25 | M40023 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 2.38e-04 | 16 | 203 | 3 | MM3766 | |
| Coexpression | LEE_BMP2_TARGETS_DN | NOLC1 UNC5B SRPK1 PFAS CHD1 LRRC59 RCC2 TAF4B HSPE1 DPH2 TTF2 POLR1A TCOF1 XPO4 BTAF1 NARS2 SLC7A1 SH3PXD2A | 2.51e-04 | 904 | 203 | 18 | M2325 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | LIN7C CHD1 NEK4 PLAGL1 ATP13A3 HERC2 AGTPBP1 ANK3 TENT5A NSD1 APC NUP214 KANSL1 SETD5 PHF3 TNKS VPS13B | 8.49e-08 | 369 | 200 | 17 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | CHD1 USP7 PLAGL1 ATP13A3 HERC2 AGTPBP1 ANK3 SFSWAP TENT5A APC NUP214 KANSL1 SETD5 PHF3 TNKS VPS13B HDLBP | 1.56e-07 | 385 | 200 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | LIN7C BCAT1 IRAG1 USP7 PLAGL1 ATP13A3 ALCAM HERC2 RAB27B AGTPBP1 COPA TENT5A NSD1 APC XPO4 NUP214 ZFPM2 SETD5 PHF3 CGNL1 GRHL3 PCDH7 AHNAK2 HDLBP | 7.34e-07 | 811 | 200 | 24 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | LIN7C USP7 PLAGL1 ATP13A3 ALCAM HERC2 AGTPBP1 COPA NSD1 APC XPO4 NUP214 SETD5 PHF3 CGNL1 HDLBP | 1.22e-06 | 397 | 200 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | NEK4 PLAGL1 ATP13A3 HERC2 ANK3 TENT5A NSD1 APC KANSL1 SETD5 PHF3 | 2.41e-06 | 194 | 200 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CHD1 USP7 PLAGL1 ATP13A3 HERC2 RAB27B AGTPBP1 ANK3 SFSWAP TENT5A APC LAMB1 NUP214 KANSL1 SLC12A2 SETD5 PHF3 TNKS LTBP1 GRHL3 VPS13B HDLBP | 1.01e-05 | 818 | 200 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | HLA-C ALMS1 UBQLN2 KIF21A PCLO PHF3 MDC1 PAM CDK11B PAN3 CDC25C | 3.67e-05 | 259 | 200 | 11 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | HLA-C SPTBN2 CFAP20DC HAP1 KIF21A PCLO SLC12A2 LRP11 CDH8 TP53BP1 | 5.69e-05 | 225 | 200 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | CHD1 ATP13A3 ANK3 PMPCB NSD1 APC LAMB1 DNM1L NUP214 KANSL1 PHF3 VPS13B HDLBP | 6.66e-05 | 379 | 200 | 13 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | LIN7C CHD1 NEK4 PLAGL1 ATP13A3 HERC2 AGTPBP1 ANK3 TENT5A NSD1 APC NUP214 KANSL1 SLC12A2 SETD5 PHF3 TNKS GRHL3 PCDH7 VPS13B | 7.96e-05 | 806 | 200 | 20 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | CHD1 PTPN13 ALCAM HSP90AB3P TENT5A CAMSAP3 CREB3L1 TDRD7 LRP11 PAM | 8.47e-05 | 236 | 200 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#2 | NOLC1 PTPN13 AJAP1 ALCAM PLS3 HSPE1 L3MBTL2 TENT5A CREB3L1 TDRD7 PAM | 1.44e-04 | 302 | 200 | 11 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | NOLC1 GAK HLA-C UNC5B BCAT1 SRPK1 RPS27A RCC2 EHD3 CFAP20DC AHNAK ADAM17 HSP90AB3P ANAPC15 KIF21A XPO4 KANSL1 SLC12A2 SETD5 MACF1 SPRTN TP53BP1 | 1.55e-04 | 983 | 200 | 22 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 |
| CoexpressionAtlas | e10.5_MaxilArch_top-relative-expression-ranked_500_5 | 1.70e-04 | 12 | 200 | 3 | Facebase_ST1_e10.5_MaxilArch_500_5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | NOLC1 HLA-C CNBD2 PTPN13 AJAP1 ALMS1 RAB6A HSP90AB3P TTF2 CNOT11 UBQLN2 HAP1 KIF21A PCLO CAMSAP3 PHF3 LRP11 MDC1 PAM CDK11B PAN3 CDC25C | 1.81e-04 | 994 | 200 | 22 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | BCAT1 IRAG1 PLAGL1 ATP13A3 ALCAM RAB27B AGTPBP1 TENT5A NSD1 ZFPM2 PHF3 GRHL3 HDLBP | 1.89e-04 | 421 | 200 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | PLAGL1 ATP13A3 PRRC2B ANK3 TENT5A APC NUP214 KANSL1 PHF3 TNKS HDLBP | 1.92e-04 | 312 | 200 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | NOLC1 HLA-C BCAT1 NEK4 PTPN13 AJAP1 HSP90AB3P HSPE1 L3MBTL2 TCOF1 HAP1 KIF21A CAMSAP3 LRP11 | 2.70e-04 | 496 | 200 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | LIN7C USP7 ATP13A3 HERC2 AGTPBP1 TENT5A NSD1 APC KANSL1 SETD5 PHF3 | 3.10e-04 | 330 | 200 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.14e-04 | 97 | 200 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#1_top-relative-expression-ranked_200 | 3.18e-04 | 35 | 200 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 3.56e-04 | 231 | 200 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | NOLC1 HLA-C BCAT1 CLSTN2 RPS27A PTPN13 AJAP1 SUOX PLAGL1 DMD PLS3 HSP90AB3P HSPE1 L3MBTL2 HAP1 KIF21A CAMSAP3 DNAH2 LRP11 PEAK1 CDH8 | 3.72e-04 | 976 | 200 | 21 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000 | LIN7C HLA-C SAMD12 AHNAK PLAGL1 ALCAM ANKRD40 RAB6A PLS3 HSDL2 SYNE1 BTAF1 NARS2 FRY SH3PXD2A RASL11A PAM MACF1 CGNL1 | 3.77e-04 | 838 | 200 | 19 | gudmap_kidney_adult_Podocyte_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | CHD1 USP7 ATP13A3 ANK3 NSD1 APC LAMB1 NUP214 KANSL1 PCDH7 HDLBP | 3.89e-04 | 339 | 200 | 11 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | NOLC1 SDE2 LIN7C HLA-C BCAT1 CHD1 NEK4 PTPN13 AJAP1 BTF3 HSP90AB1 HSP90AB3P HSPE1 POLR1A L3MBTL2 TCOF1 HAP1 KIF21A PCLO CAMSAP3 LRP11 | 4.54e-04 | 991 | 200 | 21 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | NOLC1 SDE2 SPTBN2 PFAS RCC2 GTF3C3 CFAP20DC B4GALNT3 CNOT11 DNAJC13 ANAPC15 XPO4 EIF3B | 4.70e-04 | 463 | 200 | 13 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CHD1 GALNT16 ALMS1 PLAGL1 ALCAM DMD HSP90AB1 HSDL2 KIF21A PCLO DNAH2 BTAF1 DZANK1 PAM CDK11B CDH8 | 4.90e-04 | 654 | 200 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | NEK4 PLAGL1 ATP13A3 HERC2 ANK3 TENT5A NSD1 APC KANSL1 SETD5 PHF3 GRHL3 | 5.15e-04 | 408 | 200 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | NOLC1 LIN7C PIH1D2 BCAT1 SRPK1 CHD1 CNBD2 NEK4 PTPN13 ALMS1 ATP13A3 HSPE1 TTF2 UBQLN2 TCOF1 HAP1 KIF21A GPX3 CREB3L1 UBE2O SETD5 CDK11B PAN3 TDP1 CDC25C MYB | 5.21e-04 | 1371 | 200 | 26 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 5.38e-04 | 149 | 200 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | HLA-C CHD1 NEK4 ALMS1 USP7 TTF2 UBQLN2 MYO19 KIF21A PCLO BTAF1 CYRIB PHF3 PAN3 | 5.44e-04 | 532 | 200 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | IRAG1 CPED1 ALCAM DMD PZP HSP90AB1 FLNA ANK3 SYNE1 TACC2 ZFPM2 LTBP1 | 1.58e-10 | 200 | 204 | 12 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | IRAG1 CPED1 ALCAM DMD PZP HSP90AB1 FLNA TSHZ3 SYNE1 TACC2 ZFPM2 LTBP1 | 1.58e-10 | 200 | 204 | 12 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | FBXO40 CPED1 B4GALNT3 ANK3 HSDL2 KIF21A TACC2 FRY PAM PCDH7 MYBPC3 | 1.52e-09 | 192 | 204 | 11 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | EFHB CFAP54 EFCAB12 PZP WDR49 ANK3 DNAH2 BEST4 PCDH7 CFAP46 AHNAK2 | 1.61e-09 | 193 | 204 | 11 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | HLA-A UBC PTPN13 HSP90AB1 HSPE1 ANK3 SYNE1 RNF17 PHF3 MACF1 FRMPD3 | 1.89e-09 | 196 | 204 | 11 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | IRAG1 CPED1 ALCAM DMD PZP HSP90AB1 FLNA BAZ2B SYNE1 ZFPM2 LTBP1 | 2.22e-09 | 199 | 204 | 11 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SAMD12 PIGR ALCAM RAB27B DOP1B MIA3 ANK3 TACC2 CREB3L1 SLC12A2 CGNL1 | 2.34e-09 | 200 | 204 | 11 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | IRAG1 CPED1 DMD PZP HSP90AB1 FLNA BAZ2B SYNE1 TACC2 ZFPM2 LTBP1 | 2.34e-09 | 200 | 204 | 11 | 08bf8c00eee6468215edb3611296bfc8784c4d56 |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.42e-08 | 184 | 204 | 10 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | FBXO40 CPED1 B4GALNT3 DMD ANK3 KIF21A TACC2 FRY PCDH7 MYBPC3 | 2.46e-08 | 195 | 204 | 10 | 75fc81bddb246dca3b437fb60827b1d4fe416405 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-08 | 199 | 204 | 10 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.13e-08 | 200 | 204 | 10 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.13e-08 | 200 | 204 | 10 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | ERBB2 PTPN13 AHNAK ALCAM ANK3 KIF21A PCLO SH3PXD2A PCDH7 AHNAK2 | 3.13e-08 | 200 | 204 | 10 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.13e-08 | 200 | 204 | 10 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.13e-08 | 200 | 204 | 10 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 176 | 204 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-07 | 180 | 204 | 9 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.63e-07 | 181 | 204 | 9 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-07 | 182 | 204 | 9 | d1a1feef318062f25493355d7beee8e5fb0e4206 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.96e-07 | 185 | 204 | 9 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-07 | 185 | 204 | 9 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-07 | 186 | 204 | 9 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.24e-07 | 188 | 204 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-07 | 188 | 204 | 9 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.35e-07 | 189 | 204 | 9 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.45e-07 | 190 | 204 | 9 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.45e-07 | 190 | 204 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.45e-07 | 190 | 204 | 9 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-07 | 192 | 204 | 9 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.68e-07 | 192 | 204 | 9 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.80e-07 | 193 | 204 | 9 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.93e-07 | 194 | 204 | 9 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.93e-07 | 194 | 204 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-07 | 194 | 204 | 9 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.06e-07 | 195 | 204 | 9 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.19e-07 | 196 | 204 | 9 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-07 | 196 | 204 | 9 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-07 | 196 | 204 | 9 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.33e-07 | 197 | 204 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.33e-07 | 197 | 204 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.48e-07 | 198 | 204 | 9 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.63e-07 | 199 | 204 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.78e-07 | 200 | 204 | 9 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.78e-07 | 200 | 204 | 9 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Parenchymal-10x5prime|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.78e-07 | 200 | 204 | 9 | 4bb6e1129bdf62a90b7e6c9740459129b92e3c02 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.78e-07 | 200 | 204 | 9 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | Bronchial-10x5prime|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.78e-07 | 200 | 204 | 9 | b8cf3d202e26513fcacc0a8467670dd71f69f74b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.78e-07 | 200 | 204 | 9 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.78e-07 | 200 | 204 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.78e-07 | 200 | 204 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.67e-07 | 157 | 204 | 8 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 169 | 204 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-06 | 175 | 204 | 8 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.65e-06 | 177 | 204 | 8 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-06 | 179 | 204 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-06 | 180 | 204 | 8 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-06 | 182 | 204 | 8 | 1e2149b222a3e9f64841aed45288a6f29394e7b0 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.03e-06 | 182 | 204 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-06 | 183 | 204 | 8 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-06 | 184 | 204 | 8 | 5cfc19ffb9f074bdf0d81c86e212a708ec141631 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.29e-06 | 185 | 204 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-06 | 185 | 204 | 8 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.29e-06 | 185 | 204 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.29e-06 | 185 | 204 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-06 | 188 | 204 | 8 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-06 | 188 | 204 | 8 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-06 | 188 | 204 | 8 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-06 | 188 | 204 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.58e-06 | 188 | 204 | 8 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-06 | 189 | 204 | 8 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.68e-06 | 189 | 204 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.68e-06 | 189 | 204 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.68e-06 | 189 | 204 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.79e-06 | 190 | 204 | 8 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.79e-06 | 190 | 204 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-06 | 190 | 204 | 8 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-06 | 190 | 204 | 8 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.79e-06 | 190 | 204 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-06 | 191 | 204 | 8 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-06 | 191 | 204 | 8 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.90e-06 | 191 | 204 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.90e-06 | 191 | 204 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-06 | 191 | 204 | 8 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 192 | 204 | 8 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 192 | 204 | 8 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-06 | 192 | 204 | 8 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-06 | 192 | 204 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.02e-06 | 192 | 204 | 8 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-06 | 193 | 204 | 8 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.13e-06 | 193 | 204 | 8 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 3.13e-06 | 193 | 204 | 8 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-06 | 193 | 204 | 8 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | ILEUM-inflamed-(2)_B_cell-(2)_Memory_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.13e-06 | 193 | 204 | 8 | a2ca508b1a6184579083f59419f4701c28d379ab | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 3.26e-06 | 194 | 204 | 8 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 3.26e-06 | 194 | 204 | 8 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.26e-06 | 194 | 204 | 8 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.26e-06 | 194 | 204 | 8 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.26e-06 | 194 | 204 | 8 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.26e-06 | 194 | 204 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| Drug | M6 - t | 6.25e-09 | 9 | 201 | 5 | CID004477692 | |
| Drug | AC1LASJR | 9.78e-07 | 60 | 201 | 7 | CID000474231 | |
| Drug | 2c5o | NOLC1 GAK SRPK1 RPS27A UBA52 UBB UBC BTF3 USP7 ANK3 APC CDK11B CDC25C | 1.58e-06 | 284 | 201 | 13 | CID000447956 |
| Drug | Shikoccin | 2.69e-06 | 4 | 201 | 3 | CID000327536 | |
| Drug | Ula 1 | 2.69e-06 | 4 | 201 | 3 | CID003047135 | |
| Drug | uranium-bromide | 2.69e-06 | 4 | 201 | 3 | CID000083507 | |
| Drug | A-52 | 2.76e-06 | 12 | 201 | 4 | CID000120355 | |
| Drug | NSC302991 | NOLC1 LPIN1 UBA52 UBB UBC FDXR RAG1 POLR1A CHTF18 MDC1 TNKS TDP1 CDC25C TP53BP1 | 3.34e-06 | 353 | 201 | 14 | CID000002538 |
| Drug | Papet | 6.69e-06 | 5 | 201 | 3 | CID005310950 | |
| Drug | 4-(oxyacetyl)phenoxyacetic acid | 6.69e-06 | 5 | 201 | 3 | CID000170173 | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; HL60; HG-U133A | PRPF31 UNC5B FAXDC2 ARL6IP4 LPIN1 AP3D1 SFSWAP TCOF1 CIDEC ZNF197 | 9.25e-06 | 194 | 201 | 10 | 1611_DN |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; HL60; HG-U133A | PRPF31 LIN7C FAXDC2 ARL6IP4 PLAGL1 HERC1 ANKRD40 PRRC2B DPH2 DNAJC13 | 1.01e-05 | 196 | 201 | 10 | 1624_DN |
| Drug | L2-G | 2.31e-05 | 7 | 201 | 3 | CID009549184 | |
| Disease | serum albumin measurement | ZC3H11B ADAR PLEKHM1 MIP MIA3 DNAJC13 FRY THRB SLC12A2 MACF1 PCDH7 TP53BP1 HDLBP MYBPC3 | 4.10e-05 | 592 | 194 | 14 | EFO_0004535 |
| Disease | Congenital diaphragmatic hernia | 4.30e-05 | 2 | 194 | 2 | cv:C0235833 | |
| Disease | Diaphragmatic hernia | 4.30e-05 | 2 | 194 | 2 | cv:C0019284 | |
| Disease | Cleft uvula | 4.30e-05 | 2 | 194 | 2 | C0266122 | |
| Disease | Cleft of hard palate | 4.30e-05 | 2 | 194 | 2 | C0432090 | |
| Disease | Cleft Soft Palate | 4.30e-05 | 2 | 194 | 2 | C0432098 | |
| Disease | Submucous cleft of hard palate | 4.30e-05 | 2 | 194 | 2 | C0432103 | |
| Disease | platelet component distribution width | HEMGN EHD3 GSE1 TMCC2 USP7 ATP13A3 HERC1 PLS3 THEMIS2 SYNE1 DNM1L ZFPM2 UBE2O THRB MACF1 MYB | 4.31e-05 | 755 | 194 | 16 | EFO_0007984 |
| Disease | mean platelet volume | HLA-C IRAG1 RCC2 EHD3 GSE1 TMCC2 USP7 ATP13A3 WDR49 PLS3 PCDHGC5 COL6A6 PCDHGA1 DNM1L ZFPM2 FRY LTBP1 MYB MYBPC3 | 4.74e-05 | 1020 | 194 | 19 | EFO_0004584 |
| Disease | advanced glycosylation end product-specific receptor, soluble measurement | 7.62e-05 | 13 | 194 | 3 | EFO_0020131 | |
| Disease | Malignant neoplasm of breast | ERBB2 SLCO2B1 CFHR5 ADAR GALNT16 HERC2 DMD PLS3 THEMIS2 FLNA SYNE1 TACC2 NUP214 SLC6A3 PAEP MACF1 VPS13B TP53BP1 HDLBP | 9.34e-05 | 1074 | 194 | 19 | C0006142 |
| Disease | bone fracture | 1.00e-04 | 112 | 194 | 6 | EFO_0003931 | |
| Disease | osteopetrosis (is_implicated_in) | 1.28e-04 | 3 | 194 | 2 | DOID:13533 (is_implicated_in) | |
| Disease | Submucous cleft palate | 1.28e-04 | 3 | 194 | 2 | C4551487 | |
| Disease | Diarrhea | 1.47e-04 | 16 | 194 | 3 | HP_0002014 | |
| Disease | Colorectal Carcinoma | SPTBN2 CHD1 CLSTN2 MFF LPIN1 GSE1 DMD PZP WDR49 AGTPBP1 TCOF1 SYNE1 APC RASL11A | 2.44e-04 | 702 | 194 | 14 | C0009402 |
| Disease | Gastrointestinal Neoplasms | 2.56e-04 | 4 | 194 | 2 | C0017185 | |
| Disease | Malignant neoplasm of gastrointestinal tract | 2.56e-04 | 4 | 194 | 2 | C0685938 | |
| Disease | Glioma | 2.79e-04 | 87 | 194 | 5 | C0017638 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 3.41e-04 | 21 | 194 | 3 | EFO_0006790, EFO_0008343 | |
| Disease | sexual dimorphism measurement | LIN7C ZNF165 ZC3H11B RAD54L2 CNBD2 B4GALNT3 HERC1 AP3D1 TENT5A NSD1 APC FEZ2 MACF1 TNKS LTBP1 TP53BP1 HDLBP MYBPC3 | 3.93e-04 | 1106 | 194 | 18 | EFO_0021796 |
| Disease | Uveal Melanoma | 4.12e-04 | 53 | 194 | 4 | EFO_1000616 | |
| Disease | Progeria | 4.24e-04 | 5 | 194 | 2 | C0033300 | |
| Disease | intraocular pressure measurement | MFF ALCAM HERC2 TTF2 PCLO FEZ2 SH3PXD2A LTBP1 CDC25C HDLBP MYBPC3 | 5.87e-04 | 509 | 194 | 11 | EFO_0004695 |
| Disease | unipolar depression, bipolar disorder | 6.00e-04 | 156 | 194 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | cognitive function measurement, self reported educational attainment | 6.05e-04 | 355 | 194 | 9 | EFO_0004784, EFO_0008354 | |
| Disease | glucagon measurement, glucose tolerance test | 6.34e-04 | 6 | 194 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | contactin-2 measurement | 6.34e-04 | 6 | 194 | 2 | EFO_0008100 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 6.34e-04 | 6 | 194 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | Lissencephaly | 6.34e-04 | 6 | 194 | 2 | C0266463 | |
| Disease | Lymphatic Metastasis | 6.51e-04 | 26 | 194 | 3 | C0024232 | |
| Disease | lymphocyte:monocyte ratio | 6.73e-04 | 288 | 194 | 8 | EFO_0600088 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 7.29e-04 | 27 | 194 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | ERBB2 CHD1 USP7 HSP90AB1 RAG1 PCDH11Y GPX3 APC SLC4A2 SLC7A1 SLC12A2 ZMYM3 | 8.29e-04 | 616 | 194 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | ERBB2 CHD1 USP7 HSP90AB1 RAG1 PCDH11Y GPX3 APC SLC4A2 SLC7A1 SLC12A2 ZMYM3 | 8.29e-04 | 616 | 194 | 12 | C0376358 |
| Disease | serum IgE measurement | 8.46e-04 | 64 | 194 | 4 | EFO_0004579 | |
| Disease | mean reticulocyte volume | HLA-A SRPK1 CHD1 CPED1 TMCC2 HSP90AB1 POLR1A DNAH2 CYRIB THRB KANSL1 CHTF18 MYB HDLBP | 8.73e-04 | 799 | 194 | 14 | EFO_0010701 |
| Disease | graft-versus-host disease (implicated_via_orthology) | 8.84e-04 | 7 | 194 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | muscular atrophy (biomarker_via_orthology) | 9.01e-04 | 29 | 194 | 3 | DOID:767 (biomarker_via_orthology) | |
| Disease | prostate cancer (is_implicated_in) | 1.08e-03 | 117 | 194 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | bone density | 1.13e-03 | 388 | 194 | 9 | EFO_0003923 | |
| Disease | monocyte count | HLA-A HLA-C SPTBN2 IRAG1 PLEKHM1 EHD3 GSE1 TMCC2 PLAGL1 AP3D1 THEMIS2 TTF2 BAZ2B TENT5A ZFPM2 THRB PAN3 MYB MYBPC3 | 1.18e-03 | 1320 | 194 | 19 | EFO_0005091 |
| Disease | Malignant Glioma | 1.18e-03 | 70 | 194 | 4 | C0555198 | |
| Disease | mixed gliomas | 1.18e-03 | 70 | 194 | 4 | C0259783 | |
| Disease | stomach cancer (is_implicated_in) | 1.31e-03 | 72 | 194 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | prostate cancer (implicated_via_orthology) | 1.32e-03 | 33 | 194 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | Parkinson disease | 1.35e-03 | 321 | 194 | 8 | MONDO_0005180 | |
| Disease | Drugs used in diabetes use measurement | 1.55e-03 | 255 | 194 | 7 | EFO_0009924 | |
| Disease | Autoinflammatory disorder | 1.57e-03 | 35 | 194 | 3 | C3860213 | |
| Disease | reticulocyte measurement | HLA-A HLA-C HLA-H HEMGN ZC3H11B PFAS EHD3 AHNAK TMCC2 FLNA NARS2 CYRIB UBE2O THRB KANSL1 SLC12A2 | 1.68e-03 | 1053 | 194 | 16 | EFO_0010700 |
| Disease | Abnormality of refraction | ZC3H11B PZP TSHZ3 DNAJC13 ANK3 TENT5A PCLO TDRD7 FRY THRB PEAK1 PCDH7 | 1.75e-03 | 673 | 194 | 12 | HP_0000539 |
| Disease | Autistic Disorder | 1.77e-03 | 261 | 194 | 7 | C0004352 | |
| Disease | osteoarthritis, hand | 1.84e-03 | 37 | 194 | 3 | EFO_1000789 | |
| Disease | irritability measurement | 2.12e-03 | 82 | 194 | 4 | EFO_0009594 | |
| Disease | Gastric cancer | 2.27e-03 | 11 | 194 | 2 | cv:C0024623 | |
| Disease | Neoplasm of stomach | 2.27e-03 | 11 | 194 | 2 | cv:C0038356 | |
| Disease | Epithelioid Cell Uveal Melanoma | 2.27e-03 | 11 | 194 | 2 | EFO_1000244 | |
| Disease | beta-2 microglobulin measurement | 2.27e-03 | 11 | 194 | 2 | EFO_0005197 | |
| Disease | ovarian carcinoma, COVID-19 | 2.27e-03 | 11 | 194 | 2 | EFO_0001075, MONDO_0100096 | |
| Disease | Paranoia | 2.27e-03 | 11 | 194 | 2 | C1456784 | |
| Disease | GASTRIC CANCER | 2.27e-03 | 11 | 194 | 2 | 613659 | |
| Disease | immature reticulocyte measurement | 2.31e-03 | 40 | 194 | 3 | EFO_0803545 | |
| Disease | liver fibrosis measurement | 2.53e-03 | 86 | 194 | 4 | EFO_0010576 | |
| Disease | brain disease (is_implicated_in) | 2.72e-03 | 12 | 194 | 2 | DOID:936 (is_implicated_in) | |
| Disease | Childhood Medulloblastoma | 2.85e-03 | 43 | 194 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 2.85e-03 | 43 | 194 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 2.85e-03 | 43 | 194 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 2.85e-03 | 43 | 194 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 2.85e-03 | 43 | 194 | 3 | C0278876 | |
| Disease | Intellectual Disability | 2.95e-03 | 447 | 194 | 9 | C3714756 | |
| Disease | waist-hip ratio | HLA-C ZC3H11B CPED1 GSE1 AHNAK ADAM17 MINDY4 AP3D1 THEMIS2 ANK3 TENT5A NSD1 LAMB1 HS1BP3 TDRD7 PAM RIMS1 | 3.14e-03 | 1226 | 194 | 17 | EFO_0004343 |
| Disease | Seizures | 3.29e-03 | 218 | 194 | 6 | C0036572 | |
| Disease | total cortical area measurement | 3.48e-03 | 94 | 194 | 4 | EFO_0008381 | |
| Disease | obsolete_red blood cell distribution width | HEMGN UBL4A TMCC2 HERC1 HSP90AB1 THEMIS2 DNAJC13 POLR1A L3MBTL2 BAZ2B MYO19 CYRIB ZFPM2 THRB KANSL1 SLC12A2 STKLD1 MYB | 3.53e-03 | 1347 | 194 | 18 | EFO_0005192 |
| Disease | body surface area | ZC3H11B CPED1 B4GALNT3 RAB27B POLR1A TENT5A NSD1 FEZ2 SETD5 MACF1 LTBP1 | 3.69e-03 | 643 | 194 | 11 | EFO_0022196 |
| Disease | beta-2-microglobulin measurement | 3.72e-03 | 14 | 194 | 2 | EFO_0020180 | |
| Disease | reticulocyte count | HLA-A HLA-C HLA-H ZC3H11B EHD3 AHNAK TMCC2 HERC1 HSP90AB1 NARS2 CYRIB TMX2 UBE2O THRB KANSL1 | 3.97e-03 | 1045 | 194 | 15 | EFO_0007986 |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 4.27e-03 | 15 | 194 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | anemia (implicated_via_orthology) | 4.27e-03 | 15 | 194 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 4.35e-03 | 307 | 194 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | Medulloblastoma | 4.37e-03 | 50 | 194 | 3 | C0025149 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 4.37e-03 | 50 | 194 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | eosinophil count | HLA-A HLA-C SAMD12 CHD1 EHD3 KPNA7 GSE1 SUOX USP7 PLAGL1 THEMIS2 FLNA KANSL1 SLC12A2 PEAK1 CDC25C TP53BP1 MYB HDLBP | 4.47e-03 | 1488 | 194 | 19 | EFO_0004842 |
| Disease | basophil count | 4.87e-03 | 483 | 194 | 9 | EFO_0005090 | |
| Disease | breast milk measurement | 5.34e-03 | 106 | 194 | 4 | EFO_0009092 | |
| Disease | immature platelet count | 5.34e-03 | 106 | 194 | 4 | EFO_0803544 | |
| Disease | Benign neoplasm of stomach | 5.48e-03 | 17 | 194 | 2 | C0153943 | |
| Disease | erythrocyte cadmium measurement | 5.48e-03 | 17 | 194 | 2 | EFO_0007807 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.48e-03 | 17 | 194 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 5.48e-03 | 17 | 194 | 2 | C0154060 | |
| Disease | sphingosine 1-phosphate measurement | 6.14e-03 | 18 | 194 | 2 | EFO_0800185 | |
| Disease | Tourette syndrome, schizophrenia | 6.14e-03 | 18 | 194 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | C-reactive protein measurement | HLA-C ADAR FCER1A AHNAK TMCC2 TAF4B ANK3 CREB3L1 ZFPM2 THRB SETD5 MACF1 TNKS TP53BP1 HDLBP MYBPC3 | 6.25e-03 | 1206 | 194 | 16 | EFO_0004458 |
| Disease | Glioblastoma Multiforme | 6.28e-03 | 111 | 194 | 4 | C1621958 | |
| Disease | mean corpuscular hemoglobin concentration | SRPK1 PFAS NEK4 TMCC2 HSP90AB1 DNAJC13 POLR1A CYRIB SLC4A2 THRB CHTF18 MACF1 PAN3 VPS13B MYB | 6.56e-03 | 1105 | 194 | 15 | EFO_0004528 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QFVEPEAGAAKPQKL | 256 | Q8NFU0 | |
| EAGLDPSQRPKQKVA | 356 | Q8WVB6 | |
| PDGENVKIPVAIKVL | 741 | P04626 | |
| DGVLAVPQKPKVSLN | 21 | P12319 | |
| APGDKPKIQEVKEQR | 1076 | P04920 | |
| AEALPKQSVDGKAPL | 166 | P20290 | |
| EKDNNLVPIGKPASE | 46 | P60006 | |
| APKGITEILPILQKN | 706 | Q96N23 | |
| PVIKAEPLEVNQFLK | 181 | Q96BA8 | |
| KVESRVKAQLQEPGP | 141 | Q9H0I2 | |
| NVPQVGPDRLEKLKN | 191 | P55884 | |
| ELKKINPDVNPQLGI | 86 | Q8N336 | |
| QAKNAEGKRPVELVP | 226 | Q96DX5 | |
| TILKEKPDPNNLVFG | 36 | P54687 | |
| TKVPVGDQPKDIELQ | 151 | O00429 | |
| PFDAIENKKAAVPQI | 541 | A4D0V7 | |
| KIDQPEKQGLEQPGF | 411 | Q6L9W6 | |
| VIIAEALPPKDGKVA | 771 | Q9H7F0 | |
| LIVPSPDVLKAGNKN | 401 | Q9UIF8 | |
| PDVEKLEKGLNDLQP | 171 | Q9Y673 | |
| PVDFLGLQDKIKEVP | 256 | P22570 | |
| KQEPGENSEILPTLK | 106 | P22352 | |
| SDIPKAAEPGKLEQV | 941 | Q14687 | |
| EALKVSNVPGPADQK | 1781 | Q8TCU4 | |
| DQAAALVPKAGLAKP | 106 | Q9UKB5 | |
| QDIGEKPAVRIQNPK | 6 | Q53H64 | |
| QPVSVKVGDKVLLPE | 61 | P61604 | |
| LPVQPGEIKPLDAKD | 1566 | Q8IYW2 | |
| KAFEAQNPDPKAPVV | 136 | Q9BQC3 | |
| VNLPKADVDISGPKI | 771 | Q09666 | |
| PKVDIKAPDVEGQGL | 1106 | Q09666 | |
| VNLPKADIDVSGPKV | 1276 | Q09666 | |
| NLPKADVVVSGPKVD | 2071 | Q09666 | |
| NLPKADVDVSGPKVD | 2266 | Q09666 | |
| PEVDIKGPKVDINAP | 2611 | Q09666 | |
| KGPKVDINAPDVGVQ | 2616 | Q09666 | |
| LKGPKVDIDVPDVNV | 2871 | Q09666 | |
| VNLPKADVDVSGPKV | 2916 | Q09666 | |
| GPKVDIKAPEVNLNA | 3446 | Q09666 | |
| IKGPKVDINAPDVDV | 3781 | Q09666 | |
| VNLPKADLDVSGPKV | 3826 | Q09666 | |
| PDINIEGLDAKVKTP | 5171 | Q09666 | |
| QVFKLDPNNKEGPVL | 601 | P19021 | |
| AAGAKVDEIPGNPVK | 251 | Q6NSI1 | |
| VDEIPGNPVKRLFNK | 256 | Q6NSI1 | |
| GVNPDQVEKIRKLPN | 301 | Q6AI12 | |
| AAATVNPVLAPKKAE | 391 | Q8N283 | |
| AKAGLQVKPEVPSQE | 551 | Q8N283 | |
| PLFPGKSEIDQINKV | 636 | P21127 | |
| AQAPPVAQEALKKEL | 1226 | P11532 | |
| EKEPAPQVSLNVKGI | 911 | Q9Y4B4 | |
| DILAQVKPLGPQLAD | 501 | Q15517 | |
| KPAAQDTLVQVDVKP | 241 | Q9H4D0 | |
| RQGAKVPDGIVPKNL | 361 | Q9H4D0 | |
| LKPQQEPGRTIEDLK | 406 | Q9UPW5 | |
| VLKPDFVQVKDLPDG | 316 | Q9P1Y5 | |
| ENKVQAKPPKVDGAE | 71 | O14646 | |
| KQEVDSAPQLPKVDL | 296 | Q6NXP0 | |
| AQKKVPVPEGLDLDA | 611 | O14617 | |
| PVKEALPGIIKQGVN | 426 | Q8N428 | |
| VLKGAKPDVSNGQPE | 236 | P30301 | |
| QSPAVLDKADGQKPV | 61 | P15918 | |
| LDKADGQKPVPTQPL | 66 | P15918 | |
| IEKTKDGQILPVPNV | 316 | Q9P258 | |
| PDIVLIGNKADLPDQ | 126 | O00194 | |
| QDIPVGDLKPAIVKV | 1441 | P20742 | |
| LGVRPKNQPIATEEK | 2081 | Q96L73 | |
| AKVPERKLQANGPVA | 61 | Q14978 | |
| IKLEKPQEQPVSEGG | 191 | P20340 | |
| LENGKETLQRADPPK | 196 | P01893 | |
| AAVGPIKQLPDFKQI | 466 | O75439 | |
| IPQTKQDLELPKLAG | 21 | P09466 | |
| DSGKELKIDIIPNPQ | 66 | P08238 | |
| EKNPPLKLVIEAGLI | 101 | A9QM74 | |
| KDAPPLSKAGQDVVL | 206 | Q86VZ4 | |
| LEKLQRSGEVPPQKL | 21 | Q9NUP9 | |
| EEGKAPQAVPLEKSQ | 381 | Q14676 | |
| EKLKVAPPNADLEQG | 51 | Q9GZY8 | |
| LRQGSKKPLLEDDPQ | 641 | Q969R5 | |
| KDNPLDPVLAKVAGD | 116 | Q96AG4 | |
| AGLVEKNKDPIPPEL | 541 | Q96H55 | |
| SAKFKELGIQPVPLQ | 1751 | O95714 | |
| DSGKELKIDIIPNPQ | 66 | Q58FF7 | |
| PQVKGGDEKSPLVDI | 1746 | Q9Y3R5 | |
| KPVDVKNPSVPLVDG | 666 | Q8WW38 | |
| VEGTQEKILQPKLAP | 386 | Q15751 | |
| EPNVPKGLADRKQND | 241 | Q9Y6F6 | |
| LENGKETLQRAEPPK | 196 | P10321 | |
| SPGVDPKQLAAELQK | 4616 | Q9Y6V0 | |
| LNQIAPKGQKEGEPR | 306 | P13797 | |
| LDQEKTKLEPGQPQL | 811 | Q14766 | |
| KDGKPFPELVLEQQL | 186 | Q9Y5F6 | |
| TPDGEKQPQLIVKGA | 251 | O60245 | |
| NNVFGIVPLAKPEEK | 621 | Q92614 | |
| KQPRQPKGAVDDAIA | 1121 | Q9H792 | |
| DIVTGEKNEPVKPLQ | 431 | P51957 | |
| NPTKEDLGKLQPLVA | 66 | Q7Z3B3 | |
| NPAIIDDPNLVVKIG | 496 | Q14693 | |
| NLLIQNKPGDDPNKI | 66 | P35658 | |
| NKPGDDPNKIVDKVQ | 71 | P35658 | |
| DPNKIVDKVQGLLVP | 76 | P35658 | |
| EEKLQLQPKPRSGAV | 296 | Q6YN16 | |
| KDILAQSPAAEPLKN | 1231 | P07942 | |
| IVAEFQENGPPLLKK | 511 | P10242 | |
| VKAKIQDKEGIPPDQ | 26 | P62987 | |
| GLFPKIQEIAEPKDL | 296 | Q9BXL5 | |
| LKIGPQLKELNPEEG | 5841 | Q9UPN3 | |
| TTVPKLDKNPNLGED | 171 | P30307 | |
| KDAPQVLPGQLSVKL | 736 | Q86UR5 | |
| KLGTINERPEFQKDP | 786 | Q58A45 | |
| EQQDILSKFGKPELP | 741 | O14976 | |
| QVGKNEPVDPVKLRQ | 116 | Q96IV6 | |
| PLPSKQAKEGDLQRV | 501 | Q8TE85 | |
| DLDQILNLGAEPKPK | 311 | Q53T59 | |
| LKQIEFLKGQLPEAP | 41 | P55265 | |
| PKAVKAQIADLPAGS | 991 | O14981 | |
| PGVDQLIEKFDQKPG | 351 | Q0VF96 | |
| APLQVKVQGPKGLVE | 1481 | P21333 | |
| LGPKPEVAQQTRKIL | 1131 | P53621 | |
| QKNLSLLSPVPEDKG | 921 | Q5JV73 | |
| EKEQVANKGEPLALP | 26 | Q9BXY8 | |
| VPQEELGAAKKVPAE | 561 | P54257 | |
| KEKAEAQQVEALPGP | 126 | Q66PJ3 | |
| AQPVPDEIVKKILGN | 1181 | Q12955 | |
| PPQLSNGEVKEIRKE | 211 | Q9BXR6 | |
| KSAKIVDGPDPENII | 1356 | O75165 | |
| LENGKETLQRTDPPK | 196 | P04439 | |
| KPEVAPELSEGRKNN | 546 | Q9UH90 | |
| KPNTEIKLPVEVDIG | 181 | Q8N7U6 | |
| KVLKDQPPNSVEGLL | 286 | Q9NUQ9 | |
| EKPLTKSLQRGEDPQ | 91 | Q5TBA9 | |
| INGFLPRKDIKPDLQ | 691 | P55286 | |
| PITLPDGKIQVKAIA | 71 | Q9NVP4 | |
| QNVKGPQKDPEELVA | 16 | P0DP71 | |
| QNVKGPQKDPEELVA | 16 | A0A1B0GTK5 | |
| NLGIFKIEQPPSKDL | 1206 | Q9P225 | |
| GLAKEQIDPALFAKP | 431 | Q6IQ49 | |
| LQKGDVIQIIEKPPV | 196 | O75995 | |
| IQVLPPKNAIKEGDN | 251 | Q13740 | |
| VPGPLKATLKEDVLQ | 2201 | A6NMZ7 | |
| KKNGPPSVEDLQILT | 311 | Q9UHY8 | |
| GIPSKELENLQELKP | 2211 | Q12923 | |
| IKLLAADAGKPPLNQ | 466 | Q9BZA8 | |
| IPGNLPFKLEKLVDN | 386 | Q9Y5H4 | |
| ENGLDPQAAIPVIKK | 6 | Q9Y4G2 | |
| PDSKAPVIIVGNKGD | 136 | Q6T310 | |
| DKPVIGTPVQIKLAQ | 496 | Q92750 | |
| LQTLKNPLPEAEAGK | 691 | Q12872 | |
| AGKVNLPKELPADAV | 356 | Q9UM63 | |
| EDGLDIPKTQFLQPK | 1021 | O95602 | |
| LKEIEQNGPSRQPKD | 361 | O75069 | |
| KEASEIPLGPQNKQL | 1401 | Q8NF91 | |
| EDKVQLTVPPGIKND | 361 | Q5JRA6 | |
| LTVPPGIKNDDKNIL | 366 | Q5JRA6 | |
| ALKVLAQKASEAQPP | 1076 | Q13428 | |
| QLEPSGKLKVPEENF | 196 | Q96I59 | |
| SQAGDIAAEKLVPKP | 591 | Q9C0A6 | |
| PRLLINKEKAGQSDP | 281 | Q8IXJ6 | |
| VPDQKGTPKRLQAEA | 46 | Q8N8I0 | |
| GNFLVNPLEPKNAEK | 476 | Q96SB4 | |
| LPLPTDKIQKDAGQA | 406 | Q8NHU6 | |
| EGIIPGNALVVDPKK | 106 | Q9NZN3 | |
| QQLGQPEKALEALEP | 501 | Q9Y5Q9 | |
| LKGPQIDVKGPNVDL | 2746 | Q8IVF2 | |
| PNVDLKGPKAEVTAP | 2756 | Q8IVF2 | |
| VPKVDLKGPQIDVNV | 4391 | Q8IVF2 | |
| LKGPQIDVNVPKLDL | 4396 | Q8IVF2 | |
| QIRILKSPQEVKPGE | 281 | P78536 | |
| IQVDAPDQKGTEIKP | 2726 | P25054 | |
| PVIKAKDLSAQQVPA | 496 | Q6ZVT6 | |
| QLLDATEEGQPPKGK | 211 | Q96AQ7 | |
| NIKPGELPKEAAVGA | 396 | Q96M20 | |
| TPTAEKQLEKPLENG | 141 | Q8NA57 | |
| PQQTQLLGELEKDPK | 341 | Q9UKZ1 | |
| DGVLIVDLQKPPPNK | 616 | Q9BXT8 | |
| PQLLLPKDQVSGKAV | 201 | Q8WWB5 | |
| KLSKAGDNIPEEQPV | 266 | Q9Y320 | |
| VLPPKRQKSGSQEDL | 71 | Q9NUW8 | |
| PNPVQLDKGLKELET | 221 | Q6P1L6 | |
| QKDLDGPAIQVPVLV | 121 | O14709 | |
| LGPPEVIAQLENAAK | 6 | Q9C0E2 | |
| PVRKNQLLPSDKVDG | 356 | Q4G0A6 | |
| EQLLKANPPGKDRIV | 916 | O15020 | |
| VEQQLLVSGPGKKPE | 691 | O94956 | |
| DGIIVNKAPLEKVPD | 491 | Q8NE28 | |
| IAIKNGLPAPDFKVN | 131 | Q7Z4S6 | |
| GEEVKNPQKAIPVGI | 276 | P30825 | |
| EGGQKDPKQRIIPFL | 61 | Q5TCZ1 | |
| AAKQIINEELKPPGV | 61 | Q5VZP5 | |
| GEQPVKSLLDPKVAA | 726 | O15067 | |
| PTKKNRDGNTPLDLV | 776 | O95271 | |
| EAKPPQEDLKGALVA | 276 | Q6NSZ9 | |
| PNAVGPKEVELILVK | 21 | Q01959 | |
| GPIVPLNVADQKLLE | 996 | P55011 | |
| DLTVVKAKGQPDLPE | 506 | Q5TEJ8 | |
| QKRKFLPEDIGQAPI | 241 | P10828 | |
| NIGALEELPEVNKPA | 616 | Q8IV35 | |
| PLQGLEIVNPQAAEK | 456 | Q8WWY3 | |
| LLEKAQALPNGVPKA | 1151 | Q9C0C9 | |
| AAPKPDLIIFLEQGK | 46 | P0DKX0 | |
| IVLGPDAQKKLQQVP | 126 | Q8IZ13 | |
| IQEPAANKSLEKPEG | 1076 | Q92576 | |
| KGNDPNIVIVPKDGT | 71 | Q5JSZ5 | |
| PPARLQVEKKQQLAG | 1466 | O95359 | |
| QKKLQSGEPVELENP | 406 | Q12888 | |
| KIIEGEPNLKVPGNV | 456 | P01833 | |
| LRKNFDQEPLGKEVP | 151 | Q8IZJ1 | |
| VKAKIQDKEGIPPDQ | 26 | P0CG47 | |
| NVKAKIQDKEGIPPD | 101 | P0CG47 | |
| ENVKAKIQDKEGIPP | 176 | P0CG47 | |
| KIQDKEGIPPDQQRL | 181 | P0CG47 | |
| EPVENGKELVKPLAS | 686 | Q63HK5 | |
| EPVLAAENKDKPNRG | 231 | Q9H040 | |
| VLQEPPAKKAAVDAV | 691 | A0A1B0GTU1 | |
| PKTLAIPEKLQEAVG | 26 | Q6P7N7 | |
| IGPNSKLNLVVKPLE | 61 | P11441 | |
| GKGQEKPLQNIEPDL | 2876 | Q7Z7G8 | |
| GPALNVKLQPVETKA | 156 | P49910 | |
| GTELKAPLKQEPLQV | 96 | Q6PML9 | |
| KIGELNPEDKVAPTV | 156 | P51687 | |
| DPAQKSDIVQLRGPK | 546 | Q00341 | |
| QGSAAAPAEPKIIKV | 21 | Q9UHD9 | |
| VKAKIQDKEGIPPDQ | 26 | P0CG48 | |
| NVKAKIQDKEGIPPD | 101 | P0CG48 | |
| ENVKAKIQDKEGIPP | 176 | P0CG48 | |
| KIQDKEGIPPDQQRL | 181 | P0CG48 | |
| AKIQDKEGIPPDQQR | 256 | P0CG48 | |
| VKAKIQDKEGIPPDQ | 406 | P0CG48 | |
| NVKAKIQDKEGIPPD | 481 | P0CG48 | |
| ENVKAKIQDKEGIPP | 556 | P0CG48 | |
| KIQDKEGIPPDQQRL | 561 | P0CG48 | |
| AKIQDKEGIPPDQQR | 636 | P0CG48 | |
| LDFLPEGVNKEKITP | 166 | Q96IP4 | |
| VKAKIQDKEGIPPDQ | 26 | P62979 | |
| LQEAEKGVKFLTLPP | 386 | Q93009 | |
| PEENGNLGKIPVKTR | 796 | Q14202 | |
| QPGPLTLELQIAKDK | 311 | Q12836 | |
| KEIPTNKQEAEIPGA | 701 | Q9UNY4 | |
| DSPDVQGKILPKSEQ | 81 | Q8WWM1 | |
| KVGEPVNLLIPFQGK | 986 | Q14896 |